
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500003B850B218B45.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="plosone" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3470581/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470581/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma" /><meta name="citation_author" content="Walid Abushahba" /><meta name="citation_author_institution" content="Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_author" content="Oyenike O. Olabisi" /><meta name="citation_author_institution" content="Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_author" content="Byeong-Seon Jeong" /><meta name="citation_author_institution" content="Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_author" content="Rajeev K. Boregowda" /><meta name="citation_author_institution" content="Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_author" content="Yu Wen" /><meta name="citation_author_institution" content="Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_author" content="Fang Liu" /><meta name="citation_author_institution" content="Center for Advanced Biotechnology and Medicine, Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America" /><meta name="citation_author" content="James S. Goydos" /><meta name="citation_author_institution" content="Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_author" content="Ahmed Lasfar" /><meta name="citation_author_institution" content="Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America" /><meta name="citation_author" content="Karine A. Cohen-Solal" /><meta name="citation_author_institution" content="Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America" /><meta name="citation_publication_date" content="2012" /><meta name="citation_issue" content="10" /><meta name="citation_volume" content="7" /><meta name="citation_doi" content="10.1371/journal.pone.0047312" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3470581/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3470581/" /><meta name="citation_pmid" content="23077590" /><meta name="DC.Title" content="Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="PLOS" /><meta name="DC.Contributor" content="Walid Abushahba" /><meta name="DC.Contributor" content="Oyenike O. Olabisi" /><meta name="DC.Contributor" content="Byeong-Seon Jeong" /><meta name="DC.Contributor" content="Rajeev K. Boregowda" /><meta name="DC.Contributor" content="Yu Wen" /><meta name="DC.Contributor" content="Fang Liu" /><meta name="DC.Contributor" content="James S. Goydos" /><meta name="DC.Contributor" content="Ahmed Lasfar" /><meta name="DC.Contributor" content="Karine A. Cohen-Solal" /><meta name="DC.Date" content="2012" /><meta name="DC.Identifier" content="10.1371/journal.pone.0047312" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma" /><meta property="og:type" content="article" /><meta property="og:description" content="Riluzole, an inhibitor of glutamate release, has shown the ability to inhibit melanoma cell xenograft growth. A phase 0 clinical trial of riluzole as a single agent in patients with melanoma resulted in involution of tumors associated with inhibition ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470581/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3470581/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22PLoS%20One%22[journal]" class="navlink">PLoS One</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3470581
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3470581/pdf/pone.0047312.pdf" class="int-view">PDF (1.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3470581/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3470581/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3470581" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3470581%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="n7moo1biUrfeJsudBUcBG00N7CHY93n4QlFxpxeRtkbzKBV55mTY4PJISjBghNL8">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3470581%2F&amp;text=Non-Canonical%20Smads%20Phosphorylation%20Induced%20by%20the%20Glutamate%20Release%20Inhibitor%2C%20Riluzole%2C%20through%20GSK3%20Activation%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3470581%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470581/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3470581/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/23077590/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3470581/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/23077590/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3470581/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3470581/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22PLoS%20One%22[journal]" class="navlink">PLoS One</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3470581
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-plosone.png" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://journals.plos.org/plosone/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">PLoS One.</span> 2012; 7(10): e47312. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2012 Oct 12. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0047312" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0047312</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3470581</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23077590">23077590</a></div></div></div><h1 class="content-title">Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Abushahba%20W%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110622293200" co-class="co-affbox">Walid Abushahba</a>,<sup>#</sup><sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Olabisi%20OO%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110622427616" co-class="co-affbox">Oyenike O. Olabisi</a>,<sup>#</sup><sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jeong%20BS%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110626678128" co-class="co-affbox">Byeong-Seon Jeong</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Boregowda%20RK%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110623271328" co-class="co-affbox">Rajeev K. Boregowda</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wen%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110623268960" co-class="co-affbox">Yu Wen</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20F%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110663818720" co-class="co-affbox">Fang Liu</a>,<sup>
3
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Goydos%20JS%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110624165760" co-class="co-affbox">James S. Goydos</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lasfar%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110623416304" co-class="co-affbox">Ahmed Lasfar</a>,<sup>
4
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Cohen-Solal%20KA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140110615686288" co-class="co-affbox">Karine A. Cohen-Solal</a><sup>
1
,</sup><sup>
*
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140110622293200"><h3 class="no_margin">Walid Abushahba</h3><p>
<sup>1</sup>
Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Abushahba%20W%5BAuthor%5D">Walid Abushahba</a></div></div><div id="_co_idm140110622427616"><h3 class="no_margin">Oyenike O. Olabisi</h3><p>
<sup>1</sup>
Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Olabisi%20OO%5BAuthor%5D">Oyenike O. Olabisi</a></div></div><div id="_co_idm140110626678128"><h3 class="no_margin">Byeong-Seon Jeong</h3><p>
<sup>2</sup>
Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jeong%20BS%5BAuthor%5D">Byeong-Seon Jeong</a></div></div><div id="_co_idm140110623271328"><h3 class="no_margin">Rajeev K. Boregowda</h3><p>
<sup>1</sup>
Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Boregowda%20RK%5BAuthor%5D">Rajeev K. Boregowda</a></div></div><div id="_co_idm140110623268960"><h3 class="no_margin">Yu Wen</h3><p>
<sup>2</sup>
Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wen%20Y%5BAuthor%5D">Yu Wen</a></div></div><div id="_co_idm140110663818720"><h3 class="no_margin">Fang Liu</h3><p>
<sup>3</sup>
Center for Advanced Biotechnology and Medicine, Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20F%5BAuthor%5D">Fang Liu</a></div></div><div id="_co_idm140110624165760"><h3 class="no_margin">James S. Goydos</h3><p>
<sup>2</sup>
Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Goydos%20JS%5BAuthor%5D">James S. Goydos</a></div></div><div id="_co_idm140110623416304"><h3 class="no_margin">Ahmed Lasfar</h3><p>
<sup>4</sup>
Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lasfar%20A%5BAuthor%5D">Ahmed Lasfar</a></div></div><div id="_co_idm140110615686288"><h3 class="no_margin">Karine A. Cohen-Solal</h3><p>
<sup>1</sup>
Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Cohen-Solal%20KA%5BAuthor%5D">Karine A. Cohen-Solal</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Marie-Jos&#x000e9;e Boucher, <span class="fm-role">Editor</span><sup></sup></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140110625376064_ai idm140110622293328_ai idm140110618514624_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140110625376064_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140110625376064_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140110625376064_ai" style="display:none"><div class="fm-affl" id="aff1">
<sup>1</sup>
Department of Medicine, Division of Medical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</div><div class="fm-affl" id="aff2">
<sup>2</sup>
Department of Surgery, Division of Surgical Oncology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
</div><div class="fm-affl" id="aff3">
<sup>3</sup>
Center for Advanced Biotechnology and Medicine, Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America
</div><div class="fm-affl" id="aff4">
<sup>4</sup>
Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America
</div><div class="fm-affl" id="edit1">
University of Sherbrooke, Canada
</div><div><sup>#</sup>Contributed equally.</div><div id="cor1">* E-mail: <a href="mailto:dev@null" data-email="ude.jndmu@aksnehoc" class="oemail">ude.jndmu@aksnehoc</a></div><div id="fn-a.k.b.m.b"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</div><div><p class="p p-first-last">Conceived and designed the experiments: KAC-S. Performed the experiments: WA OOO B-SJ RKB FL. Analyzed the data: B-SJ KAC-S. Contributed reagents/materials/analysis tools: YW FL JG AL. Wrote the paper: KAC-S.</p></div></div><div class="fm-article-notes hide half_rhythm" id="idm140110625376064_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 May 16; Accepted 2012 Sep 11.</div></div><div class="permissions half_rhythm hide" id="idm140110625376064_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2012 Abushahba et al</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.k.b.u" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.k.b.utitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Riluzole, an inhibitor of glutamate release, has shown the ability to inhibit melanoma cell xenograft growth. A phase 0 clinical trial of riluzole as a single agent in patients with melanoma resulted in involution of tumors associated with inhibition of both the mitogen-activated protein kinase (MAPK) and phophoinositide-3-kinase/AKT (PI3K/AKT) pathways in 34% of patients. In the present study, we demonstrate that riluzole inhibits AKT-mediated glycogen synthase kinase 3 (GSK3) phosphorylation in melanoma cell lines. Because we have demonstrated that GSK3 is involved in the phosphorylation of two downstream effectors of transforming growth factor beta (TGF&#x003b2;), Smad2 and Smad3, at their linker domain, our aim was to determine whether riluzole could induce GSK3&#x003b2;-mediated linker phosphorylation of Smad2 and Smad3. We present evidence that riluzole increases Smad2 and Smad3 linker phosphorylation at the cluster of serines 245/250/255 and serine 204 respectively. Using GSK3 inhibitors and siRNA knock-down, we demonstrate that the mechanism of riluzole-induced Smad phosphorylation involved GSK3&#x003b2;. In addition, GSK3&#x003b2; could phosphorylate the same linker sites <em>in vitro</em>. The riluzole-induced Smad linker phosphorylation is mechanistically different from the Smad linker phosphorylation induced by TGF&#x003b2;. We also demonstrate that riluzole-induced Smad linker phosphorylation is independent of the expression of the metabotropic glutamate receptor 1 (GRM1), which is one of the glutamate receptors whose involvement in human melanoma has been documented. We further show that riluzole upregulates the expression of INHBB and PLAU, two genes associated with the TGF&#x003b2; signaling pathway. The non-canonical increase in Smad linker phosphorylation induced by riluzole could contribute to the modulation of the pro-oncogenic functions of Smads in late stage melanomas.</p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">Transforming growth factor-beta (TGF&#x003b2;) plays a dual role in melanoma, mediating tumor suppressive activities at early stages and prooncogenic activities at later stages of tumor progression <a href="#pone.0047312-Javelaud1" rid="pone.0047312-Javelaud1" class=" bibr popnode">[1]</a>, <a href="#pone.0047312-Lasfar1" rid="pone.0047312-Lasfar1" class=" bibr popnode">[2]</a>. At the cell surface, TGF-&#x003b2; binds a complex of transmembrane receptor serine/threonine kinases (types I and II) and induces transphosphorylation and activation of the type I receptor (T&#x003b2;R-I, ALK5) by the type II receptor kinase (T&#x003b2;R-II). The activated type I receptor phosphorylates the downstream effectors Smad2 and Smad3 at C-terminal serines <a href="#pone.0047312-Abdollah1" rid="pone.0047312-Abdollah1" class=" bibr popnode">[3]</a>, <a href="#pone.0047312-Nakao1" rid="pone.0047312-Nakao1" class=" bibr popnode">[4]</a>, <a href="#pone.0047312-Souchelnytskyi1" rid="pone.0047312-Souchelnytskyi1" class=" bibr popnode">[5]</a>. Smad2 and Smad3 then associate with a common Smad4, and these activated complexes translocate into the nucleus, where they regulate transcription of target genes <a href="#pone.0047312-Massague1" rid="pone.0047312-Massague1" class=" bibr popnode">[6]</a>, <a href="#pone.0047312-Siegel1" rid="pone.0047312-Siegel1" class=" bibr popnode">[7]</a>. The linker region of Smad2 and Smad3, between the MH1 (N-terminal) and MH2 (C-terminal) domains, has been shown to be the target of mitogen-activated protein kinases (MAPK), including ERK, JNK and p38, cyclin-dependent kinases (CDK) and glycogen synthase kinase 3&#x003b2; (GSK3&#x003b2;). Four sites within the linker region have been the focus of several studies: Threonine 220 and Serines 245, 250 and 255 for Smad2; Threonine 179 and Serines 204, 208 and 213 for Smad3 <a href="#pone.0047312-Alarcon1" rid="pone.0047312-Alarcon1" class=" bibr popnode">[8]</a>, <a href="#pone.0047312-Chen1" rid="pone.0047312-Chen1" class=" bibr popnode">[9]</a>, <a href="#pone.0047312-CohenSolal1" rid="pone.0047312-CohenSolal1" class=" bibr popnode">[10]</a>, <a href="#pone.0047312-Gao1" rid="pone.0047312-Gao1" class=" bibr popnode">[11]</a>, <a href="#pone.0047312-Kamaraju1" rid="pone.0047312-Kamaraju1" class=" bibr popnode">[12]</a>, <a href="#pone.0047312-Kretzschmar1" rid="pone.0047312-Kretzschmar1" class=" bibr popnode">[13]</a>, <a href="#pone.0047312-Liu1" rid="pone.0047312-Liu1" class=" bibr popnode">[14]</a>, <a href="#pone.0047312-Matsuura1" rid="pone.0047312-Matsuura1" class=" bibr popnode">[15]</a>, <a href="#pone.0047312-Matsuura2" rid="pone.0047312-Matsuura2" class=" bibr popnode">[16]</a>, <a href="#pone.0047312-Millet1" rid="pone.0047312-Millet1" class=" bibr popnode">[17]</a>, <a href="#pone.0047312-Mori1" rid="pone.0047312-Mori1" class=" bibr popnode">[18]</a>, <a href="#pone.0047312-Sekimoto1" rid="pone.0047312-Sekimoto1" class=" bibr popnode">[19]</a>, <a href="#pone.0047312-Wang1" rid="pone.0047312-Wang1" class=" bibr popnode">[20]</a>. Although it is now clear that modulation of Smad activity occurs through this linker region, the exact consequences of linker phosphorylation of Smad2 and Smad3 on their transcriptional activity is certainly linked to Smad-interacting partners and the complexity of the promoters.</p><p>From studies on epithelial cells, carcinomas, gliomas and melanomas, it appears that Smads, through their linker domain, are at the point of convergence of major cellular signaling pathways, involving ERK, JNK, p38, CDK, GSK3&#x003b2;. GSK3&#x003b2; activity is negatively regulated upon AKT phosphorylation on serine 9 <a href="#pone.0047312-Cross1" rid="pone.0047312-Cross1" class=" bibr popnode">[21]</a>. Therefore, it appeared that a crosstalk between the TGF&#x003b2; signaling pathway and the AKT/GSK3&#x003b2; arm could take place through the Smad phosphorylation at their linker domain. These results altogether suggested that drugs inhibiting AKT activity could positively regulate GSK3&#x003b2; activity and subsequently increase the Smad linker phosphorylation, and modulate TGF&#x003b2; signaling.</p><p>One drug that can inhibit AKT activity is riluzole, an inhibitor of glutamate release and a FDA approved therapeutic agent for the treatment of amyotrophic lateral sclerosis <a href="#pone.0047312-Bellingham1" rid="pone.0047312-Bellingham1" class=" bibr popnode">[22]</a>. Riluzole has shown the ability to inhibit melanoma cell xenograft growth <a href="#pone.0047312-Lee1" rid="pone.0047312-Lee1" class=" bibr popnode">[23]</a>, <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a> as well as promising results in phase 0 and phase II clinical trials as a single agent in patients with melanoma <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>, <a href="#pone.0047312-Mehnert1" rid="pone.0047312-Mehnert1" class=" bibr popnode">[26]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>. The rationale for using riluzole in preclinical studies and melanoma patient trials derived from compelling evidence that the metabotropic glutamate receptor 1 (GRM1), one of the glutamate receptors, was able to induce melanoma in transgenic mice. In addition, the aberrant expression of GRM1 in approximately 65% of melanoma biopsies and cell lines reinforced the hypothesis that GRM1 could become a therapeutic target in melanoma therapy <a href="#pone.0047312-Pollock1" rid="pone.0047312-Pollock1" class=" bibr popnode">[28]</a>.</p><p class="p p-last">The present study was designed to determine whether riluzole treatment could result in GSK3&#x003b2;-mediated linker phosphorylation of Smad2 and Smad3, through the inhibition of AKT activity. We present evidence that riluzole inhibits AKT-mediated GSK3&#x003b2; phosphorylation, and increases Smad2 and Smad3 linker phosphorylation by a mechanism involving GSK3&#x003b2;. We also show that riluzole upregulates the expression of two genes associated with the TGF&#x003b2; signaling pathway, INHBB (coding for Inhibin beta B) and PLAU (coding for the urokinase plasminogen activator).</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Cell Lines</h3><p class="p p-first-last">WM793, WM278, and 1205LU were kindly provided by Dr. M. Herlyn (Wistar Institute, Philadelphia, PA, USA <a href="#pone.0047312-Satyamoorthy1" rid="pone.0047312-Satyamoorthy1" class=" bibr popnode">[29]</a>). These lines were cultured in MCDB153/L-15 (4/1 ratio) medium containing 2% FBS, 5 &#x000b5;g/ml Insulin and 1.7 mM Calcium Chloride. C8161 melanoma cell line was provided by Dr. Mary Hendrix (Children&#x02019;s Memorial Research Center, Chicago, IL, USA <a href="#pone.0047312-Welch1" rid="pone.0047312-Welch1" class=" bibr popnode">[30]</a> and was grown in D-MEM (Mediatech, 10-013-CV) containing 10% FBS. UACC930 cells and UACC903 cells were provided by Dr. Jeffrey M. Trent (Translational Genomics Research Center, Phoenix, AZ, USA <a href="#pone.0047312-Bittner1" rid="pone.0047312-Bittner1" class=" bibr popnode">[31]</a>) and were grown in RPMI1640 (Invitrogen, 11875) containing 10% FBS. The A2058 melanoma cell line was purchased from ATCC (American Type Culture Collection, Manassas, VA 20110, U.S.A) and grown in RPMI1640 containing 10% FBS <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">Reagents</h3><p class="p p-first-last">Riluzole was purchased from Tocris Biosciences. Lithium Cloride (LiCl) and SB431542 were purchased from Sigma-Aldrich. CHIR-99021 (CT99021) was purchased from Selleck Chemicals (Houston, TX, U.S.A.). Recombinant human TGF&#x003b2;1 was purchased from R&#x00026;D systems, Inc (Minneapolis, MN, U.S.A.).</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">Treatments</h3><p class="p p-first">Cells were seeded in 35 mm dishes or 6-well plates (4&#x02212;5&#x000d7;10<sup>5</sup>/dish or well). The following day, cells were serum-starved for about 16 hours before being incubated with 50 mM Nacl or 50 mM LiCl for 2 and 5 hours. For CT99021 experiment, serum-starved cells were incubated in the presence of DMSO or 2 &#x000b5;M CT99021 for two hours. For riluzole treatment, serum-starved cells were incubated with or without 25 &#x000b5;M riluzole for 9 hours in the absence or presence of either GSK3 inhibitor: LiCl (50 mM) or CT99021 (2 &#x000b5;M). For the TGF&#x003b2; treatment, serum-starved cells were incubated in the absence or presence of 200 pM TGF&#x003b2; for 1 or 2 hours.</p><p class="p p-last">In the experiments with riluzole, TGF&#x003b2; and SB431542, serum-starved cells were incubated first with or without 10 &#x000b5;M SB431542 for 1 hour, and then incubated with 25 &#x000b5;M riluzole, 200 pM TGF&#x003b2; alone or in combination for 9 hours.</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">SiRNA GSK3&#x003b1;/&#x003b2; knock-down and Riluzole Treatment</h3><p class="p p-first-last">The WM793 melanoma cell line was grown to 80% confluency. 3.10<sup>6</sup> cells were used for each transfection. Using the Nucleofector&#x02122; technology (Amaxa, Lonza), WM793 cells were transfected with 50 nM non targeting control siRNA or GSK3&#x003b1;/&#x003b2; siRNA (Cell Signaling). The cells were then resuspended in warm media and split into two wells of a 6 well tissue culture plate and placed in the 37&#x000b0;C incubator overnight. The following day, the medium was replaced with fresh culture medium for recovery. After overnight serum starvation, cells were incubated with or without 25 &#x000b5;M riluzole for 9 hours before protein extraction.</p></div><div id="s2e" class="sec"><h3 id="s2etitle">
<em>In Vitro</em> Kinase Assay</h3><p class="p p-first">Recombinant GST Smad2 and GST Smad3 fusion proteins (3 &#x000b5;g) and 1 &#x000b5;l of GSK3&#x003b2; (New England Biolabs) were incubated at 30&#x000b0;C for 1 hour in a 30 &#x000b5;l reaction containing 20 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM DTT and 0.5 mM ATP. After 1 hour incubation, SDS sample buffer was added to terminate the kinase reactions. The reaction products were then analyzed by immunoblotting using the pSmad2 (S245/250/255) and pSmad3 (S204) phosphopeptide antibodies.</p><div id="s2e1" class="sec sec-last"><p></p><h4 id="s2e1title" class="inline">Immunoblotting </h4><p class="p p-first-last">Cells were harvested, washed with phosphate-buffered saline, and extracted in the presence of protease and phosphatase inhibitors (Roche) as previously described <a href="#pone.0047312-CohenSolal1" rid="pone.0047312-CohenSolal1" class=" bibr popnode">[10]</a>. Equal amounts of protein were subjected to polyacrylamide gel electrophoresis. After transfer onto nitrocellulose membranes, immunoblots were performed using antibodies against: Both phosphoSmad3 (Thr179) and phosphoSmad2 (Thr220); phosphoSmad3 (Ser204); phosphoSmad3 (Ser208) kindly provided by Dr F. Liu (Center for Advanced Biotechnology and Medicine, Piscataway, NJ, USA) <a href="#pone.0047312-Matsuura1" rid="pone.0047312-Matsuura1" class=" bibr popnode">[15]</a>; phosphoSmad2 (Ser245/250/255); Smad2; Smad3. phospho&#x003b2;-catenin (Ser33/37/Thr41); &#x003b2;-catenin; GAPDH; phosphoAKT (S473 or T308); AKT; phosphoGSK3 (S9/S21); GSK3 (Purchased from Cell Signaling);</p></div></div><div id="s2f" class="sec"><h3 id="s2ftitle">Construction of GRM1 Over-expressing UACC903 Cell Lines</h3><p class="p p-first-last">UACC903 cells were stably transfected with the pcDNA6-GRM1 construct (Yu Wen, Jiadong Li, Seung-Shick Shin, Yong Lin, Byeong-Seon Jeong, Suzie Chen, Karine Cohen-Solal, James Goydos, manuscript submitted) by following the lipofectin (cat. No.1829037 of Invitrogen, Carlsbad, CA) transfection manual provided. Stable clones UACC903-G2 (abbreviated as G2) and UACC903-G4 (abbreviated as G4) over-expressing GRM1 were propagated under selection of 10 ug/ml Blasticidin in RPMI 1640 containing 10% FBS. Control cell line UACC903-V1 (abbreviated as V1) was derived from UACC903 transfected with pcDNA6/V5-HisA empty vector.</p></div><div id="s2g" class="sec sec-last"><h3 id="s2gtitle">RNA Isolation, TGF&#x000df;/BMP Signaling Pathway PCR Array and qPCR Validation</h3><p class="p p-first-last">Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA) and Direct-zol RNA miniprep kit (Zymo Research, Irvine, CA) following manufacturer&#x02019;s instruction. One microgram of total RNA was used for cDNA synthesis using SuperScript II cDNA synthesis kit (Invitrogen, Carlsbad, CA) for standart qPCR and RT<sup>2</sup> first strand kit (SABiosciences, Qiagen, Valencia, CA) for the TFG&#x003b2;<strong>/</strong>BMP signaling pathway PCR arrays. For the TFG&#x003b2;<strong>/</strong>BMP signaling pathway PCR array, the cDNAs were added to the RT<sup>2</sup> qPCR master mix, and the mixture was aliquoted across the PCR array, according to the manufacturer recommendations. The qPCR was performed in One Step Plus qPCR instrument (Applied Biosystems Inc, Carlsbad, CA). All primers for SYBR qRT-PCR were purchased from Qiagen (Valencia, CA). Changes in gene expression were calculated using the delta delta Ct method. All experiments were independently replicated 3 times.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">GSK3 is Involved in Smad Phosphorylation at the Linker Domain</h3><p class="p p-first">We previously demonstrated that the two pan-CDK/GSK3 inhibitors, flavopiridol <a href="#pone.0047312-Carlson1" rid="pone.0047312-Carlson1" class=" bibr popnode">[32]</a>, <a href="#pone.0047312-Rizzolio1" rid="pone.0047312-Rizzolio1" class=" bibr popnode">[33]</a>, <a href="#pone.0047312-Sedlacek1" rid="pone.0047312-Sedlacek1" class=" bibr popnode">[34]</a> and R547 <a href="#pone.0047312-Rizzolio1" rid="pone.0047312-Rizzolio1" class=" bibr popnode">[33]</a>, <a href="#pone.0047312-Chu1" rid="pone.0047312-Chu1" class=" bibr popnode">[35]</a>, <a href="#pone.0047312-DePinto1" rid="pone.0047312-DePinto1" class=" bibr popnode">[36]</a> could inhibit the constitutive linker phosphorylation of Smad2 and Smad3 in melanoma cell lines <a href="#pone.0047312-CohenSolal1" rid="pone.0047312-CohenSolal1" class=" bibr popnode">[10]</a>. In order to determine whether GSK3 was involved in Smad2 and Smad3 linker phosphorylation, we used two different types of GSK3 inhibitors: Lithium Chloride and the GSK3 specific inhibitor CT99021 <a href="#pone.0047312-Tighe1" rid="pone.0047312-Tighe1" class=" bibr popnode">[37]</a>. The effect of LiCl treatment was assessed first on &#x003b2;-catenin phosphorylation at Ser33/37/Thr41, which are GSK3 sites <a href="#pone.0047312-Polakis1" rid="pone.0047312-Polakis1" class=" bibr popnode">[38]</a>, <a href="#pone.0047312-Yost1" rid="pone.0047312-Yost1" class=" bibr popnode">[39]</a>. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g001" rid-ob="ob-pone-0047312-g001" co-legend-rid="lgnd_pone-0047312-g001"><span>Figure 1A</span></a>, treatment of human melanoma cell lines with LiCl resulted in inhibition of &#x003b2;-catenin phosphorylation at these sites. We also observed a slight increase in &#x003b2;-catenin as a result of its subsequent stabilization. Phosphorylation of Smad2 at the cluster of serines (245/250/255) was inhibited in the presence of LiCl at the two time points, 2 and 5 hours, and for the three melanoma cell lines. In addition, phosphorylation of Smad3 at serine 204 was also inhibited in the presence of LiCl similarly for 2 and 5 hours treatment. Therefore, GSK3 likely plays a role in Smad linker phosphorylation, at the cluster of serines in Smad2 and at serine 204 in Smad3. In contrast, there was a slight increase of phosphorylation at serine 208 and threonine 179 in Smad3 and threonine 220 in Smad2, in the presence of LiCl, suggesting that GSK3 normally inhibits the function of one or more kinase(s) involved in the phosphorylation at these sites. To confirm the involvement of GSK3, we used a specific inhibitor of GSK3, CT99021 <a href="#pone.0047312-Bain1" rid="pone.0047312-Bain1" class=" bibr popnode">[40]</a>. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g001" rid-ob="ob-pone-0047312-g001" co-legend-rid="lgnd_pone-0047312-g001"><span>Figure 1B</span></a>, phoshorylation of &#x003b2;-catenin is decreased and total &#x003b2;-catenin level is slightly increased as a result of CT99021 2-hour treatment. Smad2 phosphorylation at the cluster of serines (245/250/255) and Smad3 phosphorylation at serine 204 are decreased after CT99021 treatment, while phosphoSmad3 (S208) levels are increased. Phosphorylation at threonines 179 (Smad3) and 220 (Smad2) are not affected by CT99021 treatment. These results strongly suggest that GSK3 is implicated in the Smad2 and Smad3 linker phosphorylation, at the cluster of serines and at serine 204 respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0047312-g001" co-legend-rid="lgnd_pone-0047312-g001"><a href="/pmc/articles/PMC3470581/figure/pone-0047312-g001/" target="figure" rid-figpopup="pone-0047312-g001" rid-ob="ob-pone-0047312-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140110666749024"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3470581_pone.0047312.g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0047312.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3470581/bin/pone.0047312.g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140110666749024"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/figure/pone-0047312-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0047312-g001"><div><a class="figpopup" href="/pmc/articles/PMC3470581/figure/pone-0047312-g001/" target="figure" rid-figpopup="pone-0047312-g001" rid-ob="ob-pone-0047312-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Smad linker phosphorylation involves GSK3 in human melanoma lines. A.</strong><p>Inhibition of Smad2 and Smad3 linker phosphorylation in the presence of LiCl. 24 hours post seeding, WM278, WM793 and 1205LU human melanoma cell lines were serum-starved for about 16 hours, before the addition of 50 mM LiCl for 2 and 5 hours. Cells left with 50 mM NaCl for 2 or 5 hours were used as controls. Whole cell extracts were then prepared. Immunoblots were performed with antibodies against: Phosphorylated &#x003b2;-catenin (p&#x003b2;-catenin); total &#x003b2;-catenin; Both phosphoSmad3 (Thr179) and phosphoSmad2 (Thr220); phosphoSmad2 (Ser245/250/255); phosphoSmad3 (Ser204); phosphoSmad3 (Ser208); Smad2 and Smad3; GAPDH. <strong>B.</strong> Inhibition of Smad2 and Smad3 linker phosphorylation in the presence of the specific GSK3 specific inhibitor, CT99021. 24 hours post seeding, WM793 and 1205LU cells were serum-starved for about 16 hours, and incubated in the absence (&#x02212;) or presence (+) of 2 &#x000b5;M of CT99021 for two hours. Immunoblots were performed as in A. p: Phosphorylated. S: Serine; T: Threonine.</p></div></div></div></div><div id="s3b" class="sec"><h3 id="s3btitle">Riluzole Decrease AKT Phosphorylation and AKT-mediated GSK3 Phosphorylation</h3><p class="p p-first">We previously reported that riluzole inhibited phosphorylation of AKT, suggesting that this agent could negatively affect AKT activity <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g002" rid-ob="ob-pone-0047312-g002" co-legend-rid="lgnd_pone-0047312-g002"><span>Figure 2A</span></a>, riluzole decreases AKT phosphorylation on serine 473 and threonine 308. AKT phosphorylates GSK3 on serine 9 for GSK3&#x003b2; or 21 for GSK3&#x003b1;, thereby inactivating GSK3 <a href="#pone.0047312-Cross1" rid="pone.0047312-Cross1" class=" bibr popnode">[21]</a>. Therefore, we hypothesized that by inhibiting AKT activity, riluzole could decrease the phosphorylation of GSK3 at the AKT site. In order to determine whether GSK3 phosphorylation at the AKT site was decreased in the presence of riluzole, melanoma cells were incubated in the absence or presence of this agent for 4, 8 and 16 hours and GSK3&#x003b2; phosphorylation at the AKT site was analyzed. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g002" rid-ob="ob-pone-0047312-g002" co-legend-rid="lgnd_pone-0047312-g002"><span>Figure 2B</span></a>, treatment of melanoma cells with riluzole led to a decrease in AKT-mediated GSK3&#x003b2; phosphorylation on serine 9. These results suggest that riluzole could positively regulate GSK3&#x003b2; activity. Since we showed that GSK3&#x003b2; is involved in phosphorylating the Smad linker domain, we investigated whether riluzole was able to induce an increase in Smad linker phosphorylation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0047312-g002" co-legend-rid="lgnd_pone-0047312-g002"><a href="/pmc/articles/PMC3470581/figure/pone-0047312-g002/" target="figure" rid-figpopup="pone-0047312-g002" rid-ob="ob-pone-0047312-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140110625392304"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3470581_pone.0047312.g002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0047312.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3470581/bin/pone.0047312.g002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140110625392304"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/figure/pone-0047312-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0047312-g002"><div><a class="figpopup" href="/pmc/articles/PMC3470581/figure/pone-0047312-g002/" target="figure" rid-figpopup="pone-0047312-g002" rid-ob="ob-pone-0047312-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Riluzole decreases AKT phosphorylation and activity. A.</strong><p>Riluzole decreases AKT phosphorylation. Serum-starved melanoma cells were incubated in the absence (&#x02212;) or presence (+) of 25 &#x000b5;M of riluzole for 4 and 8 hours. Immunoblots were performed using antibodies against AKT phosphorylated at serine 473 (pAKT (S473)) or at threonine 308 (pAKT (T308)). Anti-total AKT and GAPDH antibodies were used for normalization. <strong>B.</strong> AKT-mediated GSK3 phosphorylation is decreased after riluzole treatment. Serum-starved melanoma cells were incubated in the absence (&#x02212;) or presence (+) of 25 &#x000b5;M of riluzole for 4, 8 and 16 hours. Immunoblots were performed using antibodies against GSK3&#x003b2; phosphorylated at serine 9, an AKT site; total GSK3&#x003b2;; GAPDH.</p></div></div></div></div><div id="s3c" class="sec"><h3 id="s3ctitle">Riluzole Increases Smad2 Linker Phosphorylation at the Cluster of Serines and Smad3 Linker Phosphorylation at Serine 204 through GSK3</h3><p class="p p-first">In order to determine whether riluzole could increase Smad linker phosphorylation, melanoma cell lines were incubated in the presence of this agent for 9 hours. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003" co-legend-rid="lgnd_pone-0047312-g003"><span>Figure 3A</span></a>, riluzole-treated cells had increased linker phosphorylation of Smad2 at serines 245/250/255 in the five melanoma cell lines tested and of Smad3 at serine 204 in all but the 1205LU cell line. As previously shown (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g001" rid-ob="ob-pone-0047312-g001" co-legend-rid="lgnd_pone-0047312-g001"><span>Figure 1</span></a>), constitutive phosphorylation of serines 245/250/255 in Smad2 and serine 204 in Smad3 involves GSK3 activity. To directly demonstrate that GSK3 mediated the Smad linker phosphorylation induced by riluzole, melanoma cell lines were treated with riluzole, in the absence or presence of pharmacological inhibitors of GSK3, LiCl and CT99021. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003" co-legend-rid="lgnd_pone-0047312-g003"><span>Figures 3B</span></a> (LiCl) and 3C (CT99021), GSK3 inhibition led to reduction of basal and riluzole-induced phosphorylation of Smad2 and Smad3 linker phosphorylation. In addition, siRNA knock-down of GSK3&#x003b1; and GSK3&#x003b2; inhibited the riluzole-induced phosphorylation of Smad2 (S245/250/255) and Smad3 (S204) (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003" co-legend-rid="lgnd_pone-0047312-g003"><span>Figure 3D</span></a>). Finally, the same sites were robustly phosphorylated by GSK3&#x003b2; in an <em>in vitro</em> kinase assay (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003" co-legend-rid="lgnd_pone-0047312-g003"><span>Figure 3E</span></a>). These results strongly suggest that riluzole, by successively inhibiting AKT and activating GSK3 activities, increases Smad linker phosphorylation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0047312-g003" co-legend-rid="lgnd_pone-0047312-g003"><a href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140110622477600"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3470581_pone.0047312.g003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0047312.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3470581/bin/pone.0047312.g003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140110622477600"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0047312-g003"><div><a class="figpopup" href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Riluzole increases Smad2 linker phosphorylation at the cluster of serines and Smad3 linker phosphorylation at serine 204 through GSK3.</strong><p>
<strong>A.</strong> Riluzole increases Smad2 and Smad3 linker phosphorylation. 24 hours post seeding, C8161, UACC930, WM278, WM793 and 1205LU human melanoma cell lines were serum-starved for about 16 hours, and incubated in the absence (&#x02212;) or presence (+) of 25 &#x000b5;M of riluzole for 9 hours. Immunoblots were performed using phosphoSmad2 (Ser245/250/255); phosphoSmad3 (Ser204); Smad2 and Smad3; GAPDH. Two exposures are presented for phosphoSmad2 (Ser245/250/255) to see the lower signals for WM278. <strong>B.</strong> LiCl treatment counteracts riluzole-induced Smad linker phosphorylation. After serum starvation, cells were incubated in the absence (&#x02212;) or presence (+) of 25 &#x000b5;M riluzole either in the presence of NaCl (&#x02212;) or LiCl (+) for 9 hours. Immunoblots were performed as in A. <strong>C.</strong> Treatment with the specific GSK3 inhibitor, CT99021, counteracts riluzole-induced Smad linker phosphorylation. After serum starvation, cells were incubated in the absence (&#x02212;) or presence (+) of 25 &#x000b5;M riluzole either in the absence (&#x02212;) or presence (+) of CT99021 (CT) for 9 hours. Immunoblots were performed as in A. <strong>D.</strong> GSK3&#x003b1; and GSK3&#x003b2; knock-down inhibits riluzole-induced Smad linker phosphorylation. WM793 melanoma cells were transfected with non targeting control siRNA (NT si) or GSK3&#x003b1;/&#x003b2; siRNA (GSK3&#x003b1;/&#x003b2; si), serum-starved and incubated with or without riluzole for 9 hours before protein extraction. Immunoblots were done as in A. <strong>E.</strong> GSK3&#x003b2; can phosphorylate the cluster of serines 245/250/255 in Smad2 and serine 204 in Smad3 <em>in vitro</em>. Recombinant GSK3&#x003b2; was used to phosphorylate GST-Smad2 and GST-Smad3 in a non radioactive reaction. The reaction products were analyzed by immunoblotting as in A. Ril: Riluzole.</p></div></div></div></div><div id="s3d" class="sec"><h3 id="s3dtitle">Riluzole does not Activate the TGF&#x003b2;/TGF&#x003b2; Receptor Complexes to Induce Smad Linker Phosphorylation</h3><p class="p p-first">It was reported that TGF&#x003b2; induced Smad3 linker phosphorylation at serine 204, 208 and threonine 179, and that GSK3 was responsible for the TGF&#x003b2;-inducible serine 204 phosphorylation, by a mechanism yet to be determined. The TGF&#x003b2;-inducible serine 204 phosphorylation required prior activation of the canonical TGF&#x003b2; signaling pathway leading to Smad3 C-terminal phosphorylation <a href="#pone.0047312-Millet1" rid="pone.0047312-Millet1" class=" bibr popnode">[17]</a>, <a href="#pone.0047312-Wang1" rid="pone.0047312-Wang1" class=" bibr popnode">[20]</a>. We therefore asked whether, in addition to a decrease in AKT-mediated GSK3 phosphorylation and subsequent GSK3 activation, riluzole could increase Smad linker phosphorylation by an additional mechanism. Indeed, riluzole treatment could also result in the activation of the TGF&#x003b2; canonical signaling pathway, subsequent GSK3 activation and Smad linker phosphorylation. We first verified that the human melanoma lines were responding to TGF&#x003b2;, as measured by an increase in the C-terminal phosphorylation of Smad2 and Smad3 (S465/467 and S423/425 respectively) upon TGF&#x003b2; treatment (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g004" rid-ob="ob-pone-0047312-g004" co-legend-rid="lgnd_pone-0047312-g004"><span>Figure 4A</span></a>). In order to determine whether riluzole could activate the TGF&#x003b2; canonical signaling pathway, we analyzed Smad2 and Smad3 C-terminal phosphorylation in the absence and presence of riluzole. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g004" rid-ob="ob-pone-0047312-g004" co-legend-rid="lgnd_pone-0047312-g004"><span>Figure 4B</span></a>, we did not observe any increase in Smad C-terminal phosphorylation in the presence of riluzole, suggesting that riluzole does not activate the canonical TGF&#x003b2; signaling pathway. To directly address the role of the TGF&#x003b2; signaling pathway in the GSK3-dependent effect of riluzole on Smad linker phosphoryation, we used an inhibitor of the TGF&#x003b2; superfamily type I activin receptor-like kinase (ALK) receptors, SB431542. SB431542 should inhibit the activation of TGF&#x003b2; receptor I resulting in an inhibition of the canonical TGF&#x003b2; signaling pathway and a decrease in Smad2 and Smad3 C-terminal phosphorylation. As shown in <a href="/pmc/articles/PMC3470581/figure/pone-0047312-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g004" rid-ob="ob-pone-0047312-g004" co-legend-rid="lgnd_pone-0047312-g004"><span>figure 4C</span></a>, we showed that the TGF&#x003b2;-induced C-terminal phosphorylation of Smad2 (pSmad2 (S465/467)) was abolished in the presence of SB431542 in C8161, UACC930 and WM793 melanoma cell lines, as expected. Interestingly, the TGF&#x003b2;-induced Smad2 linker phosphorylation (pSmad2 (S245/250/255), visible in WM793 cells, was also inhibited in the presence of SB431542, suggesting that the TGF&#x003b2;-induced Smad2 linker phosphorylation required prior C-terminal phosphorylation of Smad2 in these cells. These results are in accordance with TGF&#x003b2;-induced Smad3 linker phosphorylation requiring prior Smad3 C-terminal phosphorylation <a href="#pone.0047312-Millet1" rid="pone.0047312-Millet1" class=" bibr popnode">[17]</a>, <a href="#pone.0047312-Wang1" rid="pone.0047312-Wang1" class=" bibr popnode">[20]</a>. In contrast, riluzole-induced Smad2 linker phosphorylation was not inhibited in the presence of SB431542, indicating that riluzole effect does not require activation of the TGF&#x003b2; canonical signaling pathway to increase Smad linker phosphorylation. We obtained the same results in C8161 and UACC930 human melanoma cell lines; SB431542 did not inhibit riluzole-induced Smad2 and Smad3 linker phosphorylation in these lines. These results suggest that the only mechanism by which riluzole induces Smad linker phosphorylation is through inhibition of AKT-mediated GSK3 phosphorylation and subsequent activation of GSK3.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0047312-g004" co-legend-rid="lgnd_pone-0047312-g004"><a href="/pmc/articles/PMC3470581/figure/pone-0047312-g004/" target="figure" rid-figpopup="pone-0047312-g004" rid-ob="ob-pone-0047312-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140110663794336"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3470581_pone.0047312.g004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0047312.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3470581/bin/pone.0047312.g004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140110663794336"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/figure/pone-0047312-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0047312-g004"><div><a class="figpopup" href="/pmc/articles/PMC3470581/figure/pone-0047312-g004/" target="figure" rid-figpopup="pone-0047312-g004" rid-ob="ob-pone-0047312-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Riluzole effect on Smad linker phosphorylation does not involve the activation of the TGF&#x003b2; canonical signaling pathway.</strong><p>
<strong>A.</strong> Increased C-terminal phosphorylation in the presence of TGF&#x003b2;. Serum-starved cells were incubated in the absence (&#x02212;) or presence (+) of TGF&#x003b2; for 1 and 2 hours. Immunoblots with antibodies against the C-terminal phosphorylated form of Smad2 (pSmad2(S465/467)) or Smad3 (pSmad3(S423/425)); total Smad2 and Smad3; GAPDH. <strong>B.</strong> Riluzole does not affect the C-terminal phosphorylation of Smads. After serum starvation, cells were incubated in the absence (&#x02212;) or presence (+) of riluzole for 9 hours. Immunoblots were done as in A. <strong>C.</strong> T&#x003b2;RI inhibition by SB431542 does not decrease riluzole-induced Smad linker phosphorylation. Serum-starved C8161, UACC930 and WM793 cells were incubated in the absence (&#x02212;) or presence (+) of SB431542 for 1 hour, before incubation with riluzole and TGF&#x003b2;, alone or in combination for 9 hours. Immunoblots were performed using antibodies against the linker phosphorylated form of Smad2 (pSmad2 (S245/250/255)); the C-terminal phosphorylated form of Smad2 (pSmad2(S465/467)); total Smad2; the linker phosphorylated form of Smad3 (pSmad3 (S204); total Smad3 and GAPDH.</p></div></div></div></div><div id="s3e" class="sec"><h3 id="s3etitle">The Extent of Riluzole-induced Smad Linker Phosphorylation is Independent of GRM1 Expression in Melanoma Cells</h3><p class="p p-first">We previously mentioned that preclinical studies <em>in vitro</em> and animal models pointed to the metabotropic glutamate receptor 1 (GRM1) as a key player in melanoma development <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a>, <a href="#pone.0047312-Pollock1" rid="pone.0047312-Pollock1" class=" bibr popnode">[28]</a>, <a href="#pone.0047312-Ohtani1" rid="pone.0047312-Ohtani1" class=" bibr popnode">[41]</a>. The observation that melanoma cell lines released high levels of glutamate, resulting in a glutamate-based autocrine activation of GRM1 <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a>, prompted our group to consider riluzole as a potential therapeutic agent acting through the inhibition of glutamate release from melanoma cells <a href="#pone.0047312-Lee1" rid="pone.0047312-Lee1" class=" bibr popnode">[23]</a>, <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a>, <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>, <a href="#pone.0047312-Khan1" rid="pone.0047312-Khan1" class=" bibr popnode">[42]</a>. However, riluzole&#x02019;s effect might not be mediated through inactivation of the glutamate/GRM1-based autocrine loop. Other glutamate-based autocrine loops potentially exist in melanoma cells. Melanoma cells express and exhibit dysregulation of other glutamate receptors, including other metabotropic glutamate receptors <a href="#pone.0047312-Choi1" rid="pone.0047312-Choi1" class=" bibr popnode">[43]</a>, <a href="#pone.0047312-Prickett1" rid="pone.0047312-Prickett1" class=" bibr popnode">[44]</a>, <a href="#pone.0047312-Shin1" rid="pone.0047312-Shin1" class=" bibr popnode">[45]</a> and the ionotropic glutamate receptors <a href="#pone.0047312-Wei1" rid="pone.0047312-Wei1" class=" bibr popnode">[46]</a>. In order to determine whether riluzole&#x02019;s effect on Smad linker phosphorylation was mediated by inactivation of the GRM1 signaling pathway, we used UACC903 cells that express a low level of GRM1 and stably transfected these cells with a GRM1 expression vector (Yu Wen, Jiadong Li, Seung-Shick Shin, Yong Lin, Byeong-Seon Jeong, Suzie Chen, Karine Cohen-Solal, James Goydos, manuscript submitted). Two clones called UACC903-G2 and UACC903-G4 (abbreviated as G2 and G4 respectively), had significantly higher GRM1 expression levels than a vector control cell line UACC903-V1 (V1) (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g005" rid-ob="ob-pone-0047312-g005" co-legend-rid="lgnd_pone-0047312-g005"><span>Figure 5A</span></a>). In V1, G2 and G4 cell lines, riluzole induced Smad2 and Smad3 linker phosphorylation independently of the GRM1 expression level, indicating that the riluzole effect was not directly related to the level of GRM1 expression in these cell lines. (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g005" rid-ob="ob-pone-0047312-g005" co-legend-rid="lgnd_pone-0047312-g005"><span>Figure 5B</span></a>). In addition, in the UACC930 melanoma cell line, where the expression of GRM1 protein is not detectable <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a>, the induction of Smad2 and Smad3 linker phosphorylation in the presence of riluzole is comparable to that of the other melanoma cell lines that express GRM1 (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g003" rid-ob="ob-pone-0047312-g003" co-legend-rid="lgnd_pone-0047312-g003"><span>Figures 3A and 3B</span></a>). These results suggest that riluzole-induced Smad linker phosphorylation in melanoma cells is not directly related to GRM1 expression.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0047312-g005" co-legend-rid="lgnd_pone-0047312-g005"><a href="/pmc/articles/PMC3470581/figure/pone-0047312-g005/" target="figure" rid-figpopup="pone-0047312-g005" rid-ob="ob-pone-0047312-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140110618936912"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3470581_pone.0047312.g005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0047312.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3470581/bin/pone.0047312.g005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140110618936912"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/figure/pone-0047312-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0047312-g005"><div><a class="figpopup" href="/pmc/articles/PMC3470581/figure/pone-0047312-g005/" target="figure" rid-figpopup="pone-0047312-g005" rid-ob="ob-pone-0047312-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Riluzole-induced Smad linker phosphorylation is independent of GRM1 expression level in melanoma cells. A.</strong><p>Immunoblot with lysates from UACC903-V1 (V1) cells and two clones overexpressing GRM1, called UACC903-G2 and UACC903-G4 (abbreviated as G2 and G4 respectively). <strong>B.</strong> Riluzole-induced Smad2 and Smad3 linker phosphorylation in V1, G2 and G4 cells.</p></div></div></div></div><div id="s3f" class="sec sec-last"><h3 id="s3ftitle">Riluzole Upregulates the Expression of INHBB and PLAU</h3><p class="p p-first">The positive effect of riluzole on Smad2 and Smad3 linker phosphorylation (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g006" rid-ob="ob-pone-0047312-g006" co-legend-rid="lgnd_pone-0047312-g006"><span>Figure 6A</span></a>) prompted us to investigate the potential action of Riluzole on the expression of TGF&#x003b2; target genes. We used human TGF&#x000df;/BMP Signaling Pathway RT<sup>2</sup> Profiler&#x02122; PCR Arrays to identify known TGF&#x003b2; target genes whose expression could be modulated by riluzole. For this purpose, RNAs were isolated from WM793 melanoma cells incubated in the absence or presence of riluzole. cDNAs converted from these RNAs were processed for real-time PCR using one PCR array for the untreated cells-derived cDNA and one array for the riluzole-treated cells-derived cDNA. By comparing the two, we identified four genes whose expression was increased or decreased in the presence of riluzole as compared with untreated WM793 melanoma cells (<a href="/pmc/articles/PMC3470581/table/pone-0047312-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0047312-t001" rid-ob="ob-pone-0047312-t001" co-legend-rid=""><span>Table 1</span></a>). By qPCR, we validated the upregulation of two genes, INHBB and PLAU, in three additional melanoma cell lines (<a href="/pmc/articles/PMC3470581/figure/pone-0047312-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0047312-g006" rid-ob="ob-pone-0047312-g006" co-legend-rid="lgnd_pone-0047312-g006"><span>Figure 6B and C</span></a>). The INHBB gene codes for the inhibin, beta B chain. Two beta B subunits form a homodimer called activin B. Activin is a member of the TGF&#x003b2; superfamily <a href="#pone.0047312-McDowall1" rid="pone.0047312-McDowall1" class=" bibr popnode">[47]</a>. PLAU codes for the urokinase plasminogen activator (uPA), belonging to the urokinase plasminogen activating system (uPAS). The TGF&#x003b2; signaling positively regulates uPA expression, secretion and stability through the Smad-dependent pathway <a href="#pone.0047312-Tobar1" rid="pone.0047312-Tobar1" class=" bibr popnode">[48]</a>, <a href="#pone.0047312-Shiou1" rid="pone.0047312-Shiou1" class=" bibr popnode">[49]</a>. Therefore riluzole positively regulates the expression of genes associated with the TGF&#x003b2; signaling pathway.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0047312-g006" co-legend-rid="lgnd_pone-0047312-g006"><a href="/pmc/articles/PMC3470581/figure/pone-0047312-g006/" target="figure" rid-figpopup="pone-0047312-g006" rid-ob="ob-pone-0047312-g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140110626986032"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3470581_pone.0047312.g006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0047312.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3470581/bin/pone.0047312.g006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140110626986032"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/figure/pone-0047312-g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0047312-g006"><div><a class="figpopup" href="/pmc/articles/PMC3470581/figure/pone-0047312-g006/" target="figure" rid-figpopup="pone-0047312-g006" rid-ob="ob-pone-0047312-g006">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Riluzole upregulates the expression of genes associated with the TGF&#x003b2; signaling pathway.</strong><p>
<strong>A.</strong> Model of riluzole effect on Smad linker phosphorylation. Riluzole inhibits the phosphorylation of AKT at S473 and T308. As a result of AKT inactivation, GSK3 phosphorylation at the AKT site is decreased, resulting in GSK3 activation. GSK3 phosphorylates Smad2 at the cluster of serines 245/250/255 and Smad3 at serine 204. The consequences of these phosphorylation events on Smad2 and Smad3 activities will likely depend on the promoters of the TGF&#x003b2; target genes. <strong>B and C.</strong> Riluzole treatment increases the expression of the INHBB and PLAU genes respectively in the three independent melanoma cell lines A2058, UACC903 and C8161. mRNA from these three melanoma cell lines untreated or treated with riluzole for 24 hours were analyzed by real-time PCR for the expression of the INHBB and PLAU genes. White bars: untreated cells. Dark bars: Riluzole-treated cells. *, P&#x0003c;0.05, compared with untreated cells (t test).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="pone-0047312-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Genes whose expression was regulated by riluzole in the WM793 cell line using the Human TGF&#x003b2;/BMP Signaling Pathway RT<sup>2</sup> Profiler&#x02122; PCR Array.</strong></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Gene symbol</td><td align="left" rowspan="1" colspan="1">Fold regulation</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BMP3</td><td align="left" rowspan="1" colspan="1">&#x02212;2.46</td></tr><tr><td align="left" rowspan="1" colspan="1">GDF5</td><td align="left" rowspan="1" colspan="1">3.35</td></tr><tr><td align="left" rowspan="1" colspan="1">INHBB</td><td align="left" rowspan="1" colspan="1">2.97</td></tr><tr><td align="left" rowspan="1" colspan="1">PLAU</td><td align="left" rowspan="1" colspan="1">3.69</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140110629366192"><a target="object" rel="noopener" href="/pmc/articles/PMC3470581/table/pone-0047312-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><p class="p p-first-last">The fold increase or decrease (comparing to control) was above 2 for these four genes. BMP3: bone morphogenetic protein 3; GDF5: growth differentiation factor 5; INHBB: inhibin, beta B; PLAU: plasminogen activator, urokinase.</p></div></div></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p class="p p-first">In the present study, we described a cross-talk between three pathways involved in melanoma biology, the TGF&#x003b2; signaling pathway <a href="#pone.0047312-Javelaud1" rid="pone.0047312-Javelaud1" class=" bibr popnode">[1]</a>, <a href="#pone.0047312-Lasfar1" rid="pone.0047312-Lasfar1" class=" bibr popnode">[2]</a>, the AKT/GSK3 pathway <a href="#pone.0047312-Madhunapantula1" rid="pone.0047312-Madhunapantula1" class=" bibr popnode">[50]</a> and the glutamate signaling <a href="#pone.0047312-Lee1" rid="pone.0047312-Lee1" class=" bibr popnode">[23]</a>, <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a>, <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>, <a href="#pone.0047312-Khan1" rid="pone.0047312-Khan1" class=" bibr popnode">[42]</a>, <a href="#pone.0047312-Biechele1" rid="pone.0047312-Biechele1" class=" bibr popnode">[51]</a>. We demonstrated that the glutamate release inhibitor riluzole inhibited AKT phosphorylation at crucial sites for its activity, and consequently inhibited GSK3&#x003b2; phosphorylation at an AKT site, thereby activating GSK3&#x003b2;. We also provided evidence for the involvement of GSK3 in basal and riluzole-induced linker phosphorylation of Smad2 and Smad3. Indeed, treatment with two types of GSK3 inhibitors and the GSK3&#x003b1;/&#x003b2; knock-down counteracted basal and riluzole-induced Smad2 and Smad3 linker phosphorylation. In addition, <em>in vitro</em> kinase assays confirmed that GSK3&#x003b2; could phosphorylate Smad2 and Smad3 at the cluster of serines 245/250/255 and serine 204 respectively.</p><p>Interestingly, we also demonstrate riluzole induced Smad linker phosphorylation in the GRM1 negative UACC930 melanoma cell line <a href="#pone.0047312-Namkoong1" rid="pone.0047312-Namkoong1" class=" bibr popnode">[24]</a> (this line does not express GRM1 because of a truncation mutation [S. Chen, personal communication]). In this melanoma cell line, like in the others, GSK3 mediated the riluzole-induced Smad linker phosphorylation. However, we previously described that riluzole treatment did not inhibit AKT phosphorylation in UACC930 cells <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>. Therefore, in this line, the activation of GSK3 in the presence of riluzole would involve a different mechanism, such as Wnt signaling inactivation. These results are in apparent contradiction with a study describing riluzole as an enhancer of Wnt/&#x003b2;-catenin signaling and GRM1 as the likely target of riluzole-mediated enhancement of Wnt/&#x003b2;-catenin in the human melanoma cell line A375 and the mouse melanoma cell line B16 <a href="#pone.0047312-Biechele1" rid="pone.0047312-Biechele1" class=" bibr popnode">[51]</a>. This group also found that riluzole did not induce a decrease in ERK phosphorylation in the A375 melanoma cell line, in contrast to the decrease in phosphorylated ERK in all human melanoma cell lines positive for GRM1 <a href="#pone.0047312-Le1" rid="pone.0047312-Le1" class=" bibr popnode">[25]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>. From these results, it is likely that genetic and epigenetic context-dependent responses can be expected when treating melanoma cell lines with riluzole, as already suggested by the mixed responses to riluzole and the failure of some patients to respond to riluzole in clinical trials, independently of GRM1 expression <a href="#pone.0047312-Mehnert1" rid="pone.0047312-Mehnert1" class=" bibr popnode">[26]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>.</p><p>TGF&#x003b2;-induced Smad linker phosphorylation has been described in a wide variety of cellular systems, including melanoma cells. The different kinases involved in each of these studies include JNK, CDKs, GSK3, depending on the phosphorylation site and the cellular context <a href="#pone.0047312-Alarcon1" rid="pone.0047312-Alarcon1" class=" bibr popnode">[8]</a>, <a href="#pone.0047312-Chen1" rid="pone.0047312-Chen1" class=" bibr popnode">[9]</a>, <a href="#pone.0047312-Gao1" rid="pone.0047312-Gao1" class=" bibr popnode">[11]</a>, <a href="#pone.0047312-Millet1" rid="pone.0047312-Millet1" class=" bibr popnode">[17]</a>, <a href="#pone.0047312-Mori1" rid="pone.0047312-Mori1" class=" bibr popnode">[18]</a>, <a href="#pone.0047312-Sekimoto1" rid="pone.0047312-Sekimoto1" class=" bibr popnode">[19]</a>, <a href="#pone.0047312-Wang1" rid="pone.0047312-Wang1" class=" bibr popnode">[20]</a>, <a href="#pone.0047312-Matsuzaki1" rid="pone.0047312-Matsuzaki1" class=" bibr popnode">[52]</a>. We have shown that riluzole-induced Smad linker phosphorylation is mechanistically different from the TGF&#x003b2;-induced Smad linker phosphorylation. First, riluzole does not induce C-terminal Smad phosphorylation, suggesting that the TGF&#x003b2;/receptor complexes are not engaged upon riluzole treatment. In contrast, the initial step after TGF&#x003b2; activation is the C-terminal phosphorylation of Smad2 and Smad3, and this step is required for the TGF&#x003b2;-induced Smad3 phosphorylation <a href="#pone.0047312-Wang1" rid="pone.0047312-Wang1" class=" bibr popnode">[20]</a>. Second, riluzole does not affect the expression of TGF&#x003b2;1, TGF&#x003b2;2 or TGF&#x003b2;3 as shown by real time RT-PCR (data not shown). Therefore, this does not support the possible hypothesis that riluzole increases Smad linker phosphorylation by inducing TGF&#x003b2; production. Finally, in contrast to TGF&#x003b2;-induced Smad linker phosphorylation, the T&#x003b2;RI inhibitor, SB431542, did not inhibit the riluzole-induced Smad linker phosphorylation.</p><p>The effect of riluzole on the linker phosphorylation of Smad2 and Smad3, downstream effectors of TGF&#x003b2;, will likely modulate TGF&#x003b2; signaling and the expression of TGF&#x003b2; target genes. Our previous report suggested that Smad3 linker phosphorylation might contribute to the resistance to TGF&#x003b2;-mediated cell growth inhibition in melanoma, by inhibiting the expression of p15 and p21. However, Smad3 linker phosphorylation did not inhibit the expression of PAI-1, involved in TGF&#x003b2; pro-oncogenic effects. Therefore, Smad3 activity would be inhibited on promoters involved in cell growth inhibition, such as p15 and p21, but fully competent for regulating some of the genes involved in TGF&#x003b2; prooncogenic effects <a href="#pone.0047312-CohenSolal1" rid="pone.0047312-CohenSolal1" class=" bibr popnode">[10]</a>. This model is in accordance with the well-documented fact that not all Smad transcriptional activities have been disrupted in melanoma cells <a href="#pone.0047312-Javelaud1" rid="pone.0047312-Javelaud1" class=" bibr popnode">[1]</a>. It is now clear that Smad transcriptional activities are modulated by phosphorylation at their linker domain, but the nature of this modulation will likely depend on the promoter of each TGF&#x003b2; target gene, of the other transcription factors (repressors, activators), binding this promoter and the consequences of these phosphorylation events on the interaction between linker phosphorylated Smad and these other transcription factors. In addition, the identity of the sites phosphorylated in Smad2 and Smad3 (Threonine 220, Serines 245,250 and 255 for Smad2; Thr179 and Serines 204, 208 and 213 for Smad3) will play a role in the modulation of the TGF&#x003b2; target genes. We have shown that riluzole induces the phosphorylation of the cluster of serines (245/250/255) in Smad2 and serine 204 in Smad3 via GSK3, in the majority of the melanoma cell lines analyzed. The exact consequences of these phosphorylation events on Smad2 and Smad3 transcriptional activities will be promoter dependent, as mentioned previously.</p><p>We initiated the characterization of genes associated with the TGF&#x003b2; signaling pathway and whose expression was modulated by riluzole. Our goal was to define possible mediators of riluzole action downstream of the TGF&#x003b2; signaling pathway. Since TGF&#x003b2; exerts pro-oncogenic activities at late stages of melanoma development, it is important to determine whether riluzole can have a negative effect on the expression of genes involved in TGF&#x003b2; pro-oncogenic activities. This could explain the inhibition of melanoma cell growth in mice and the involution of some of the tumors in patients treated with riluzole. Alternatively, a positive regulation of genes involved in TGF&#x003b2; pro-oncogenic activities by riluzole could explain the mixed responses to riluzole and the failure of some patients to respond to riluzole in clinical trials <a href="#pone.0047312-Mehnert1" rid="pone.0047312-Mehnert1" class=" bibr popnode">[26]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>. We characterized two genes whose expression was upregulated by riluzole. The first one codes for inhibin beta B. Two inhibin beta B subunits form a homodimer called activin B, which is a member of the TGF&#x003b2; superfamily <a href="#pone.0047312-McDowall1" rid="pone.0047312-McDowall1" class=" bibr popnode">[47]</a>. The fact that riluzole upregulates the expression of activin B could potentially have a negative impact on riluzole response since activin is suggested to play an active role in several carcinomas and glioma migration, invasion and progression <a href="#pone.0047312-Wildi1" rid="pone.0047312-Wildi1" class=" bibr popnode">[53]</a>, <a href="#pone.0047312-Yoshinaga1" rid="pone.0047312-Yoshinaga1" class=" bibr popnode">[54]</a>, <a href="#pone.0047312-Yoshinaga2" rid="pone.0047312-Yoshinaga2" class=" bibr popnode">[55]</a>, <a href="#pone.0047312-Yoshinaga3" rid="pone.0047312-Yoshinaga3" class=" bibr popnode">[56]</a>, <a href="#pone.0047312-Zhang1" rid="pone.0047312-Zhang1" class=" bibr popnode">[57]</a>. In addition, one study suggested that melanoma cells might be resistant to the growth inhibitory and pro-apoptotic effects of activin <a href="#pone.0047312-Stove1" rid="pone.0047312-Stove1" class=" bibr popnode">[58]</a>. Resembling the dual function of TGF&#x003b2; in melanoma, melanoma cells would be resistant to activin-mediated tumor suppression, but would utilize activin to promote their migration and metastasis. The second gene whose expression was upregulated by riluzole was PLAU coding for the urokinase plasminogen activator, described as a TGF&#x003b2; target gene <a href="#pone.0047312-Tobar1" rid="pone.0047312-Tobar1" class=" bibr popnode">[48]</a>, <a href="#pone.0047312-Shiou1" rid="pone.0047312-Shiou1" class=" bibr popnode">[49]</a>. It was shown that tumor growth was retarded in uPA-deficient mice <a href="#pone.0047312-Shapiro1" rid="pone.0047312-Shapiro1" class=" bibr popnode">[59]</a>, <a href="#pone.0047312-Gutierrez1" rid="pone.0047312-Gutierrez1" class=" bibr popnode">[60]</a>. uPA belongs to the uPAS system, which plays multiple roles in the neoplastic evolution, including angiogenesis, tumor cell proliferation, adhesion, migration, intravasation and growth at the metastatic site <a href="#pone.0047312-Ulisse1" rid="pone.0047312-Ulisse1" class=" bibr popnode">[61]</a>. As suggested earlier regarding the upregulation of activin expression by riluzole, riluzole positive regulation of PLAU might contribute to the mixed responses to riluzole and the failure of some patients to respond to riluzole in clinical trials <a href="#pone.0047312-Mehnert1" rid="pone.0047312-Mehnert1" class=" bibr popnode">[26]</a>, <a href="#pone.0047312-Yip1" rid="pone.0047312-Yip1" class=" bibr popnode">[27]</a>.</p><p class="p p-last">At this point of the study, we cannot directly link the riluzole-induced linker phosphorylation of Smad2 and Smad3 to the upregulation of INHBB and PLAU expression. This would require an extensive analysis using stable transfectants expressing wild-type and Smad mutant forms unable to be phosphorylated in the specific GSK3 sites. However, our study revealed an important cross-talk between three melanoma signaling pathways, the glutamate signaling, the PI3K/AKT pathway and the TGF&#x003b2; signaling pathway. We then focused on the TGF&#x003b2; signaling pathway as a possible mediator of riluzole actions. We then identified two genes whose upregulation by riluzole might be detrimental to a more complete response to this agent in clinical trials. The identification of cross-talks such as those described in this study could be instrumental in predicting responses to riluzole-based therapy.</p></div><div id="ack-a.m.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.m.atitle">Acknowledgments</h2><div class="sec"><p>We thank Kim Merrigan and Dr Murugabaskar Balan for technical assistance.</p></div></div><div id="funding-group-a.k.b.v" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.k.b.vtitle">Funding Statement</h2><p>This work was supported by a Research Development Award from the New Jersey Commission on Cancer Research 09-1143-CCR-EO, a Research Development Award from the Cancer Center Support Grant CCSG P30CA072720, a Research Scholar Grant from the American Cancer Society 116683-RSG-09-087-01-TBE (K.C.S.) and a grant from the National Cancer Institute 1RO1CA149627-01 (J. Goydos). Dr. Olabisi was supported by a Biomedical Science Education Postdoctoral Training Program from the National Institute of Health K12 GM093854-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div><div id="ref-list-a.m.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.m.btitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0047312-Javelaud1">1. <span class="mixed-citation">
Javelaud D, Alexaki VI, Mauviel A (2008) <span class="ref-title">Transforming growth factor-beta in cutaneous melanoma</span>. <span class="ref-journal">Pigment Cell Melanoma Res</span>
<span class="ref-vol">21</span>: 123&#x02013;132. [<a href="https://pubmed.ncbi.nlm.nih.gov/18426405" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pigment+Cell+Melanoma+Res&amp;title=Transforming+growth+factor-beta+in+cutaneous+melanoma&amp;author=D+Javelaud&amp;author=VI+Alexaki&amp;author=A+Mauviel&amp;volume=21&amp;publication_year=2008&amp;pages=123-132&amp;pmid=18426405&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Lasfar1">2. <span class="mixed-citation">
Lasfar A, Cohen-Solal KA (2010) <span class="ref-title">Resistance to transforming growth factor beta-mediated tumor suppression in melanoma: are multiple mechanisms in place?</span>
<span class="ref-journal">Carcinogenesis</span>
<span class="ref-vol">31</span>: 1710&#x02013;1717. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2981460/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20656791" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Resistance+to+transforming+growth+factor+beta-mediated+tumor+suppression+in+melanoma:+are+multiple+mechanisms+in+place?&amp;author=A+Lasfar&amp;author=KA+Cohen-Solal&amp;volume=31&amp;publication_year=2010&amp;pages=1710-1717&amp;pmid=20656791&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Abdollah1">3. <span class="mixed-citation">
Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, et al. (1997) <span class="ref-title">TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">272</span>: 27678&#x02013;27685. [<a href="https://pubmed.ncbi.nlm.nih.gov/9346908" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=TbetaRI+phosphorylation+of+Smad2+on+Ser465+and+Ser467+is+required+for+Smad2-Smad4+complex+formation+and+signaling&amp;author=S+Abdollah&amp;author=M+Macias-Silva&amp;author=T+Tsukazaki&amp;author=H+Hayashi&amp;author=L+Attisano&amp;volume=272&amp;publication_year=1997&amp;pages=27678-27685&amp;pmid=9346908&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Nakao1">4. <span class="mixed-citation">
Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, et al. (1997) <span class="ref-title">TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4</span>. <span class="ref-journal">Embo J</span>
<span class="ref-vol">16</span>: 5353&#x02013;5362. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1170167/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9311995" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Embo+J&amp;title=TGF-beta+receptor-mediated+signalling+through+Smad2,+Smad3+and+Smad4&amp;author=A+Nakao&amp;author=T+Imamura&amp;author=S+Souchelnytskyi&amp;author=M+Kawabata&amp;author=A+Ishisaki&amp;volume=16&amp;publication_year=1997&amp;pages=5353-5362&amp;pmid=9311995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Souchelnytskyi1">5. <span class="mixed-citation">
Souchelnytskyi S, Tamaki K, Engstrom U, Wernstedt C, ten Dijke P, et al. (1997) <span class="ref-title">Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">272</span>: 28107&#x02013;28115. [<a href="https://pubmed.ncbi.nlm.nih.gov/9346966" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Phosphorylation+of+Ser465+and+Ser467+in+the+C+terminus+of+Smad2+mediates+interaction+with+Smad4+and+is+required+for+transforming+growth+factor-beta+signaling&amp;author=S+Souchelnytskyi&amp;author=K+Tamaki&amp;author=U+Engstrom&amp;author=C+Wernstedt&amp;author=P+ten+Dijke&amp;volume=272&amp;publication_year=1997&amp;pages=28107-28115&amp;pmid=9346966&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Massague1">6. <span class="mixed-citation">
Massague J (2008) <span class="ref-title">TGFbeta in Cancer</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">134</span>: 215&#x02013;230. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3512574/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18662538" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=TGFbeta+in+Cancer&amp;author=J+Massague&amp;volume=134&amp;publication_year=2008&amp;pages=215-230&amp;pmid=18662538&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Siegel1">7. <span class="mixed-citation">
Siegel PM, Massague J (2003) <span class="ref-title">Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer</span>. <span class="ref-journal">Nat Rev Cancer</span>
<span class="ref-vol">3</span>: 807&#x02013;821. [<a href="https://pubmed.ncbi.nlm.nih.gov/14557817" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Cytostatic+and+apoptotic+actions+of+TGF-beta+in+homeostasis+and+cancer&amp;author=PM+Siegel&amp;author=J+Massague&amp;volume=3&amp;publication_year=2003&amp;pages=807-821&amp;pmid=14557817&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Alarcon1">8. <span class="mixed-citation">
Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, et al. (2009) <span class="ref-title">Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">139</span>: 757&#x02013;769. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2818353/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19914168" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Nuclear+CDKs+drive+Smad+transcriptional+activation+and+turnover+in+BMP+and+TGF-beta+pathways&amp;author=C+Alarcon&amp;author=AI+Zaromytidou&amp;author=Q+Xi&amp;author=S+Gao&amp;author=J+Yu&amp;volume=139&amp;publication_year=2009&amp;pages=757-769&amp;pmid=19914168&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Chen1">9. <span class="mixed-citation">
Chen D, Lin Q, Box N, Roop D, Ishii S, et al. (2009) <span class="ref-title">SKI knockdown inhibits human melanoma tumor growth in vivo</span>. <span class="ref-journal">Pigment Cell Melanoma Res</span>
<span class="ref-vol">22</span>: 761&#x02013;772. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7213764/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19845874" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pigment+Cell+Melanoma+Res&amp;title=SKI+knockdown+inhibits+human+melanoma+tumor+growth+in+vivo&amp;author=D+Chen&amp;author=Q+Lin&amp;author=N+Box&amp;author=D+Roop&amp;author=S+Ishii&amp;volume=22&amp;publication_year=2009&amp;pages=761-772&amp;pmid=19845874&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-CohenSolal1">10. <span class="mixed-citation">
Cohen-Solal KA, Merrigan KT, Chan JL, Goydos JS, Chen W, et al. (2011) <span class="ref-title">Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-beta-mediated growth inhibition</span>. <span class="ref-journal">Pigment Cell Melanoma Res</span>
<span class="ref-vol">24</span>: 512&#x02013;524. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3108265/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21477078" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pigment+Cell+Melanoma+Res&amp;title=Constitutive+Smad+linker+phosphorylation+in+melanoma:+a+mechanism+of+resistance+to+transforming+growth+factor-beta-mediated+growth+inhibition&amp;author=KA+Cohen-Solal&amp;author=KT+Merrigan&amp;author=JL+Chan&amp;author=JS+Goydos&amp;author=W+Chen&amp;volume=24&amp;publication_year=2011&amp;pages=512-524&amp;pmid=21477078&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Gao1">11. <span class="mixed-citation">
Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, et al. (2009) <span class="ref-title">Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling</span>. <span class="ref-journal">Mol Cell</span>
<span class="ref-vol">36</span>: 457&#x02013;468. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2796330/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19917253" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=Ubiquitin+ligase+Nedd4L+targets+activated+Smad2/3+to+limit+TGF-beta+signaling&amp;author=S+Gao&amp;author=C+Alarcon&amp;author=G+Sapkota&amp;author=S+Rahman&amp;author=PY+Chen&amp;volume=36&amp;publication_year=2009&amp;pages=457-468&amp;pmid=19917253&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Kamaraju1">12. <span class="mixed-citation">
Kamaraju AK, Roberts AB (2005) <span class="ref-title">Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">280</span>: 1024&#x02013;1036. [<a href="https://pubmed.ncbi.nlm.nih.gov/15520018" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Role+of+Rho/ROCK+and+p38+MAP+kinase+pathways+in+transforming+growth+factor-beta-mediated+Smad-dependent+growth+inhibition+of+human+breast+carcinoma+cells+in+vivo&amp;author=AK+Kamaraju&amp;author=AB+Roberts&amp;volume=280&amp;publication_year=2005&amp;pages=1024-1036&amp;pmid=15520018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Kretzschmar1">13. <span class="mixed-citation">
Kretzschmar M, Doody J, Timokhina I, Massague J (1999) <span class="ref-title">A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras</span>. <span class="ref-journal">Genes Dev</span>
<span class="ref-vol">13</span>: 804&#x02013;816. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC316599/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10197981" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Dev&amp;title=A+mechanism+of+repression+of+TGFbeta/Smad+signaling+by+oncogenic+Ras&amp;author=M+Kretzschmar&amp;author=J+Doody&amp;author=I+Timokhina&amp;author=J+Massague&amp;volume=13&amp;publication_year=1999&amp;pages=804-816&amp;pmid=10197981&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Liu1">14. <span class="mixed-citation">
Liu F (2006) <span class="ref-title">Smad3 phosphorylation by cyclin-dependent kinases</span>. <span class="ref-journal">Cytokine Growth Factor Rev</span>
<span class="ref-vol">17</span>: 9&#x02013;17. [<a href="https://pubmed.ncbi.nlm.nih.gov/16289004" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine+Growth+Factor+Rev&amp;title=Smad3+phosphorylation+by+cyclin-dependent+kinases&amp;author=F+Liu&amp;volume=17&amp;publication_year=2006&amp;pages=9-17&amp;pmid=16289004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Matsuura1">15. <span class="mixed-citation">
Matsuura I, Denissova NG, Wang G, He D, Long J, et al. (2004) <span class="ref-title">Cyclin-dependent kinases regulate the antiproliferative function of Smads</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">430</span>: 226&#x02013;231. [<a href="https://pubmed.ncbi.nlm.nih.gov/15241418" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cyclin-dependent+kinases+regulate+the+antiproliferative+function+of+Smads&amp;author=I+Matsuura&amp;author=NG+Denissova&amp;author=G+Wang&amp;author=D+He&amp;author=J+Long&amp;volume=430&amp;publication_year=2004&amp;pages=226-231&amp;pmid=15241418&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Matsuura2">16. <span class="mixed-citation">
Matsuura I, Wang G, He D, Liu F (2005) <span class="ref-title">Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3</span>. <span class="ref-journal">Biochemistry</span>
<span class="ref-vol">44</span>: 12546&#x02013;12553. [<a href="https://pubmed.ncbi.nlm.nih.gov/16156666" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Identification+and+characterization+of+ERK+MAP+kinase+phosphorylation+sites+in+Smad3&amp;author=I+Matsuura&amp;author=G+Wang&amp;author=D+He&amp;author=F+Liu&amp;volume=44&amp;publication_year=2005&amp;pages=12546-12553&amp;pmid=16156666&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Millet1">17. <span class="mixed-citation">
Millet C, Yamashita M, Heller M, Yu LR, Veenstra TD, et al. (2009) <span class="ref-title">A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">284</span>: 19808&#x02013;19816. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2740406/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19458083" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+negative+feedback+control+of+transforming+growth+factor-beta+signaling+by+glycogen+synthase+kinase+3-mediated+Smad3+linker+phosphorylation+at+Ser-204&amp;author=C+Millet&amp;author=M+Yamashita&amp;author=M+Heller&amp;author=LR+Yu&amp;author=TD+Veenstra&amp;volume=284&amp;publication_year=2009&amp;pages=19808-19816&amp;pmid=19458083&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Mori1">18. <span class="mixed-citation">
Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, et al. (2004) <span class="ref-title">TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions</span>. <span class="ref-journal">Oncogene</span>
<span class="ref-vol">23</span>: 7416&#x02013;7429. [<a href="https://pubmed.ncbi.nlm.nih.gov/15326485" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=TGF-beta+and+HGF+transmit+the+signals+through+JNK-dependent+Smad2/3+phosphorylation+at+the+linker+regions&amp;author=S+Mori&amp;author=K+Matsuzaki&amp;author=K+Yoshida&amp;author=F+Furukawa&amp;author=Y+Tahashi&amp;volume=23&amp;publication_year=2004&amp;pages=7416-7429&amp;pmid=15326485&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Sekimoto1">19. <span class="mixed-citation">
Sekimoto G, Matsuzaki K, Yoshida K, Mori S, Murata M, et al. (2007) <span class="ref-title">Reversible Smad-dependent signaling between tumor suppression and oncogenesis</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">67</span>: 5090&#x02013;5096. [<a href="https://pubmed.ncbi.nlm.nih.gov/17545585" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Reversible+Smad-dependent+signaling+between+tumor+suppression+and+oncogenesis&amp;author=G+Sekimoto&amp;author=K+Matsuzaki&amp;author=K+Yoshida&amp;author=S+Mori&amp;author=M+Murata&amp;volume=67&amp;publication_year=2007&amp;pages=5090-5096&amp;pmid=17545585&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Wang1">20. <span class="mixed-citation">
Wang G, Matsuura I, He D, Liu F (2009) <span class="ref-title">Transforming growth factor-beta-inducible phosphorylation of Smad3</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">284</span>: 9663&#x02013;9673. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2665087/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19218245" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Transforming+growth+factor-beta-inducible+phosphorylation+of+Smad3&amp;author=G+Wang&amp;author=I+Matsuura&amp;author=D+He&amp;author=F+Liu&amp;volume=284&amp;publication_year=2009&amp;pages=9663-9673&amp;pmid=19218245&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Cross1">21. <span class="mixed-citation">
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) <span class="ref-title">Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature</span>. <span class="ref-vol">378</span>: 785&#x02013;789. [<a href="https://pubmed.ncbi.nlm.nih.gov/8524413" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=&#10;+Cross+DA+,++Alessi+DR+,++Cohen+P+,++Andjelkovich+M+,++Hemmings+BA++(+1995+)++Inhibition+of+glycogen+synthase+kinase-3+by+insulin+mediated+by+protein+kinase+B.+Nature+.++378+:++785+&#x02013;+789+.+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Bellingham1">22. <span class="mixed-citation">
Bellingham MC (2011) <span class="ref-title">A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?</span>
<span class="ref-journal">CNS Neurosci Ther</span>
<span class="ref-vol">17</span>: 4&#x02013;31. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6493865/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20236142" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CNS+Neurosci+Ther&amp;title=A+review+of+the+neural+mechanisms+of+action+and+clinical+efficiency+of+riluzole+in+treating+amyotrophic+lateral+sclerosis:+what+have+we+learned+in+the+last+decade?&amp;author=MC+Bellingham&amp;volume=17&amp;publication_year=2011&amp;pages=4-31&amp;pmid=20236142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Lee1">23. <span class="mixed-citation">
Lee HJ, Wall BA, Wangari-Talbot J, Shin SS, Rosenberg S, et al. (2011) <span class="ref-title">Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies</span>. <span class="ref-journal">Clin Cancer Res</span>
<span class="ref-vol">17</span>: 7080&#x02013;7092. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3218300/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21844014" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Glutamatergic+Pathway+Targeting+in+Melanoma:+Single-Agent+and+Combinatorial+Therapies&amp;author=HJ+Lee&amp;author=BA+Wall&amp;author=J+Wangari-Talbot&amp;author=SS+Shin&amp;author=S+Rosenberg&amp;volume=17&amp;publication_year=2011&amp;pages=7080-7092&amp;pmid=21844014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Namkoong1">24. <span class="mixed-citation">
Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, et al. (2007) <span class="ref-title">Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">67</span>: 2298&#x02013;2305. [<a href="https://pubmed.ncbi.nlm.nih.gov/17332361" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Metabotropic+glutamate+receptor+1+and+glutamate+signaling+in+human+melanoma&amp;author=J+Namkoong&amp;author=SS+Shin&amp;author=HJ+Lee&amp;author=YE+Marin&amp;author=BA+Wall&amp;volume=67&amp;publication_year=2007&amp;pages=2298-2305&amp;pmid=17332361&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Le1">25. <span class="mixed-citation">
Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, et al. (2010) <span class="ref-title">The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells</span>. <span class="ref-journal">J Invest Dermatol</span>
<span class="ref-vol">130</span>: 2240&#x02013;2249. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4004181/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20505744" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=The+glutamate+release+inhibitor+Riluzole+decreases+migration,+invasion,+and+proliferation+of+melanoma+cells&amp;author=MN+Le&amp;author=JL+Chan&amp;author=SA+Rosenberg&amp;author=AS+Nabatian&amp;author=KT+Merrigan&amp;volume=130&amp;publication_year=2010&amp;pages=2240-2249&amp;pmid=20505744&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Mehnert1">26. <span class="mixed-citation">Mehnert JM, Wen Y, Lee JH, Dudek L, Pruski-Clark L, et al.. (2011) A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor (GRM1) signaling, in advanced melanoma; Paper presented at: 2011 Annual Meeting of ASCO (American Society of Clinical Oncology) (Chicago).</span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Yip1">27. <span class="mixed-citation">
Yip D, Le MN, Chan JL, Lee JH, Mehnert JA, et al. (2009) <span class="ref-title">A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma</span>. <span class="ref-journal">Clin Cancer Res</span>
<span class="ref-vol">15</span>: 3896&#x02013;3902. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2812866/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19458050" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=A+phase+0+trial+of+riluzole+in+patients+with+resectable+stage+III+and+IV+melanoma&amp;author=D+Yip&amp;author=MN+Le&amp;author=JL+Chan&amp;author=JH+Lee&amp;author=JA+Mehnert&amp;volume=15&amp;publication_year=2009&amp;pages=3896-3902&amp;pmid=19458050&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Pollock1">28. <span class="mixed-citation">
Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, et al. (2003) <span class="ref-title">Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia</span>. <span class="ref-journal">Nat Genet</span>
<span class="ref-vol">34</span>: 108&#x02013;112. [<a href="https://pubmed.ncbi.nlm.nih.gov/12704387" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Melanoma+mouse+model+implicates+metabotropic+glutamate+signaling+in+melanocytic+neoplasia&amp;author=PM+Pollock&amp;author=K+Cohen-Solal&amp;author=R+Sood&amp;author=J+Namkoong&amp;author=JJ+Martino&amp;volume=34&amp;publication_year=2003&amp;pages=108-112&amp;pmid=12704387&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Satyamoorthy1">29. <span class="mixed-citation">
Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, et al. (2003) <span class="ref-title">Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">63</span>: 756&#x02013;759. [<a href="https://pubmed.ncbi.nlm.nih.gov/12591721" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Constitutive+mitogen-activated+protein+kinase+activation+in+melanoma+is+mediated+by+both+BRAF+mutations+and+autocrine+growth+factor+stimulation&amp;author=K+Satyamoorthy&amp;author=G+Li&amp;author=MR+Gerrero&amp;author=MS+Brose&amp;author=P+Volpe&amp;volume=63&amp;publication_year=2003&amp;pages=756-759&amp;pmid=12591721&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Welch1">30. <span class="mixed-citation">
Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, et al. (1991) <span class="ref-title">Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line</span>. <span class="ref-journal">Int J Cancer</span>
<span class="ref-vol">47</span>: 227&#x02013;237. [<a href="https://pubmed.ncbi.nlm.nih.gov/1671030" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Characterization+of+a+highly+invasive+and+spontaneously+metastatic+human+malignant+melanoma+cell+line&amp;author=DR+Welch&amp;author=JE+Bisi&amp;author=BE+Miller&amp;author=D+Conaway&amp;author=EA+Seftor&amp;volume=47&amp;publication_year=1991&amp;pages=227-237&amp;pmid=1671030&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Bittner1">31. <span class="mixed-citation">
Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, et al. (2000) <span class="ref-title">Molecular classification of cutaneous malignant melanoma by gene expression profiling</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">406</span>: 536&#x02013;540. [<a href="https://pubmed.ncbi.nlm.nih.gov/10952317" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Molecular+classification+of+cutaneous+malignant+melanoma+by+gene+expression+profiling&amp;author=M+Bittner&amp;author=P+Meltzer&amp;author=Y+Chen&amp;author=Y+Jiang&amp;author=E+Seftor&amp;volume=406&amp;publication_year=2000&amp;pages=536-540&amp;pmid=10952317&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Carlson1">32. <span class="mixed-citation">
Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ (1996) <span class="ref-title">Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">56</span>: 2973&#x02013;2978. [<a href="https://pubmed.ncbi.nlm.nih.gov/8674031" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Flavopiridol+induces+G1+arrest+with+inhibition+of+cyclin-dependent+kinase+(CDK)+2+and+CDK4+in+human+breast+carcinoma+cells&amp;author=BA+Carlson&amp;author=MM+Dubay&amp;author=EA+Sausville&amp;author=L+Brizuela&amp;author=PJ+Worland&amp;volume=56&amp;publication_year=1996&amp;pages=2973-2978&amp;pmid=8674031&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Rizzolio1">33. <span class="mixed-citation">
Rizzolio F, Tuccinardi T, Caligiuri I, Lucchetti C, Giordano A (2010) <span class="ref-title">CDK inhibitors: from the bench to clinical trials</span>. <span class="ref-journal">Curr Drug Targets</span>
<span class="ref-vol">11</span>: 279&#x02013;290. [<a href="https://pubmed.ncbi.nlm.nih.gov/20210753" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets&amp;title=CDK+inhibitors:+from+the+bench+to+clinical+trials&amp;author=F+Rizzolio&amp;author=T+Tuccinardi&amp;author=I+Caligiuri&amp;author=C+Lucchetti&amp;author=A+Giordano&amp;volume=11&amp;publication_year=2010&amp;pages=279-290&amp;pmid=20210753&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Sedlacek1">34. <span class="mixed-citation">
Sedlacek HH (2001) <span class="ref-title">Mechanisms of action of flavopiridol</span>. <span class="ref-journal">Crit Rev Oncol Hematol</span>
<span class="ref-vol">38</span>: 139&#x02013;170. [<a href="https://pubmed.ncbi.nlm.nih.gov/11311660" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Oncol+Hematol&amp;title=Mechanisms+of+action+of+flavopiridol&amp;author=HH+Sedlacek&amp;volume=38&amp;publication_year=2001&amp;pages=139-170&amp;pmid=11311660&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Chu1">35. <span class="mixed-citation">
Chu XJ, DePinto W, Bartkovitz D, So SS, Vu BT, et al. (2006) <span class="ref-title">Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-diflu oro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity</span>. <span class="ref-journal">Journal of Medicinal Chemistry</span>
<span class="ref-vol">49</span>: 6549&#x02013;6560. [<a href="https://pubmed.ncbi.nlm.nih.gov/17064073" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Medicinal+Chemistry&amp;title=Discovery+of+[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-diflu+oro-6-+methoxyphenyl)methanone+(R547),+a+potent+and+selective+cyclin-dependent+kinase+inhibitor+with+significant+in+vivo+antitumor+activity&amp;author=XJ+Chu&amp;author=W+DePinto&amp;author=D+Bartkovitz&amp;author=SS+So&amp;author=BT+Vu&amp;volume=49&amp;publication_year=2006&amp;pages=6549-6560&amp;pmid=17064073&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-DePinto1">36. <span class="mixed-citation">
DePinto W, Chu XJ, Yin X, Smith M, Packman K, et al. (2006) <span class="ref-title">In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials</span>. <span class="ref-journal">Mol Cancer Ther</span>
<span class="ref-vol">5</span>: 2644&#x02013;2658. [<a href="https://pubmed.ncbi.nlm.nih.gov/17121911" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=In+vitro+and+in+vivo+activity+of+R547:+a+potent+and+selective+cyclin-dependent+kinase+inhibitor+currently+in+phase+I+clinical+trials&amp;author=W+DePinto&amp;author=XJ+Chu&amp;author=X+Yin&amp;author=M+Smith&amp;author=K+Packman&amp;volume=5&amp;publication_year=2006&amp;pages=2644-2658&amp;pmid=17121911&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Tighe1">37. <span class="mixed-citation">
Tighe A, Ray-Sinha A, Staples OD, Taylor SS (2007) <span class="ref-title">GSK-3 inhibitors induce chromosome instability</span>. <span class="ref-journal">BMC Cell Biology</span>
<span class="ref-vol">8</span>: 34. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1976608/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17697341" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cell+Biology&amp;title=GSK-3+inhibitors+induce+chromosome+instability&amp;author=A+Tighe&amp;author=A+Ray-Sinha&amp;author=OD+Staples&amp;author=SS+Taylor&amp;volume=8&amp;publication_year=2007&amp;pages=34&amp;pmid=17697341&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Polakis1">38. <span class="mixed-citation">
Polakis P (1999) <span class="ref-title">The oncogenic activation of beta-catenin</span>. <span class="ref-journal">Curr Opin Genet Dev</span>
<span class="ref-vol">9</span>: 15&#x02013;21. [<a href="https://pubmed.ncbi.nlm.nih.gov/10072352" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Genet+Dev&amp;title=The+oncogenic+activation+of+beta-catenin&amp;author=P+Polakis&amp;volume=9&amp;publication_year=1999&amp;pages=15-21&amp;pmid=10072352&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Yost1">39. <span class="mixed-citation">
Yost C, Torres M, Miller JR, Huang E, Kimelman D, et al. (1996) <span class="ref-title">The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3</span>. <span class="ref-journal">Genes Dev</span>
<span class="ref-vol">10</span>: 1443&#x02013;1454. [<a href="https://pubmed.ncbi.nlm.nih.gov/8666229" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Dev&amp;title=The+axis-inducing+activity,+stability,+and+subcellular+distribution+of+beta-catenin+is+regulated+in+Xenopus+embryos+by+glycogen+synthase+kinase+3&amp;author=C+Yost&amp;author=M+Torres&amp;author=JR+Miller&amp;author=E+Huang&amp;author=D+Kimelman&amp;volume=10&amp;publication_year=1996&amp;pages=1443-1454&amp;pmid=8666229&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Bain1">40. <span class="mixed-citation">
Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, et al. (2007) <span class="ref-title">The selectivity of protein kinase inhibitors: a further update</span>. <span class="ref-journal">Biochem J</span>
<span class="ref-vol">408</span>: 297&#x02013;315. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2267365/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17850214" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;title=The+selectivity+of+protein+kinase+inhibitors:+a+further+update&amp;author=J+Bain&amp;author=L+Plater&amp;author=M+Elliott&amp;author=N+Shpiro&amp;author=CJ+Hastie&amp;volume=408&amp;publication_year=2007&amp;pages=297-315&amp;pmid=17850214&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Ohtani1">41. <span class="mixed-citation">
Ohtani Y, Harada T, Funasaka Y, Nakao K, Takahara C, et al. (2008) <span class="ref-title">Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma</span>. <span class="ref-journal">Oncogene</span>
<span class="ref-vol">27</span>: 7162&#x02013;7170. [<a href="https://pubmed.ncbi.nlm.nih.gov/18776920" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Metabotropic+glutamate+receptor+subtype-1+is+essential+for+in+vivo+growth+of+melanoma&amp;author=Y+Ohtani&amp;author=T+Harada&amp;author=Y+Funasaka&amp;author=K+Nakao&amp;author=C+Takahara&amp;volume=27&amp;publication_year=2008&amp;pages=7162-7170&amp;pmid=18776920&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Khan1">42. <span class="mixed-citation">
Khan AJ, Wall B, Ahlawat S, Green C, Schiff D, et al. (2011) <span class="ref-title">Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo</span>. <span class="ref-journal">Clin Cancer Res</span>
<span class="ref-vol">17</span>: 1807&#x02013;1814. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3070864/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21325066" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Riluzole+enhances+ionizing+radiation-induced+cytotoxicity+in+human+melanoma+cells+that+ectopically+express+metabotropic+glutamate+receptor+1+in+vitro+and+in+vivo&amp;author=AJ+Khan&amp;author=B+Wall&amp;author=S+Ahlawat&amp;author=C+Green&amp;author=D+Schiff&amp;volume=17&amp;publication_year=2011&amp;pages=1807-1814&amp;pmid=21325066&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Choi1">43. <span class="mixed-citation">
Choi KY, Chang K, Pickel JM, Badger JD 2nd, Roche KW (2011) <span class="ref-title">Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>
<span class="ref-vol">108</span>: 15219&#x02013;15224. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3174576/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21896768" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Expression+of+the+metabotropic+glutamate+receptor+5+(mGluR5)+induces+melanoma+in+transgenic+mice&amp;volume=108&amp;publication_year=2011&amp;pages=15219-15224&amp;pmid=21896768&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Prickett1">44. <span class="mixed-citation">
Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, et al. (2011) <span class="ref-title">Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma</span>. <span class="ref-journal">Nat Genet</span>
<span class="ref-vol">43</span>: 1119&#x02013;1126. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3376644/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21946352" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Exon+capture+analysis+of+G+protein-coupled+receptors+identifies+activating+mutations+in+GRM3+in+melanoma&amp;author=TD+Prickett&amp;author=X+Wei&amp;author=I+Cardenas-Navia&amp;author=JK+Teer&amp;author=JC+Lin&amp;volume=43&amp;publication_year=2011&amp;pages=1119-1126&amp;pmid=21946352&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Shin1">45. <span class="mixed-citation">
Shin SS, Martino JJ, Chen S (2008) <span class="ref-title">Metabotropic glutamate receptors (mGlus) and cellular transformation</span>. <span class="ref-journal">Neuropharmacology</span>
<span class="ref-vol">55</span>: 396&#x02013;402. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2605077/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18554669" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Metabotropic+glutamate+receptors+(mGlus)+and+cellular+transformation&amp;author=SS+Shin&amp;author=JJ+Martino&amp;author=S+Chen&amp;volume=55&amp;publication_year=2008&amp;pages=396-402&amp;pmid=18554669&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Wei1">46. <span class="mixed-citation">
Wei X, Walia V, Lin JC, Teer JK, Prickett TD, et al. (2011) <span class="ref-title">Exome sequencing identifies GRIN2A as frequently mutated in melanoma</span>. <span class="ref-journal">Nat Genet</span>
<span class="ref-vol">43</span>: 442&#x02013;446. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3161250/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21499247" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Exome+sequencing+identifies+GRIN2A+as+frequently+mutated+in+melanoma&amp;author=X+Wei&amp;author=V+Walia&amp;author=JC+Lin&amp;author=JK+Teer&amp;author=TD+Prickett&amp;volume=43&amp;publication_year=2011&amp;pages=442-446&amp;pmid=21499247&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-McDowall1">47. <span class="mixed-citation">
McDowall M, Edwards NM, Jahoda CA, Hynd PI (2008) <span class="ref-title">The role of activins and follistatins in skin and hair follicle development and function</span>. <span class="ref-journal">Cytokine Growth Factor Rev</span>
<span class="ref-vol">19</span>: 415&#x02013;426. [<a href="https://pubmed.ncbi.nlm.nih.gov/18922734" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine+Growth+Factor+Rev&amp;title=The+role+of+activins+and+follistatins+in+skin+and+hair+follicle+development+and+function&amp;author=M+McDowall&amp;author=NM+Edwards&amp;author=CA+Jahoda&amp;author=PI+Hynd&amp;volume=19&amp;publication_year=2008&amp;pages=415-426&amp;pmid=18922734&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Tobar1">48. <span class="mixed-citation">
Tobar N, Villar V, Santibanez JF (2010) <span class="ref-title">ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion</span>. <span class="ref-journal">Mol Cell Biochem</span>
<span class="ref-vol">340</span>: 195&#x02013;202. [<a href="https://pubmed.ncbi.nlm.nih.gov/20204677" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biochem&amp;title=ROS-NFkappaB+mediates+TGF-beta1-induced+expression+of+urokinase-type+plasminogen+activator,+matrix+metalloproteinase-9+and+cell+invasion&amp;author=N+Tobar&amp;author=V+Villar&amp;author=JF+Santibanez&amp;volume=340&amp;publication_year=2010&amp;pages=195-202&amp;pmid=20204677&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Shiou1">49. <span class="mixed-citation">
Shiou SR, Datta PK, Dhawan P, Law BK, Yingling JM, et al. (2006) <span class="ref-title">Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">281</span>: 33971&#x02013;33981. [<a href="https://pubmed.ncbi.nlm.nih.gov/16959768" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Smad4-dependent+regulation+of+urokinase+plasminogen+activator+secretion+and+RNA+stability+associated+with+invasiveness+by+autocrine+and+paracrine+transforming+growth+factor-beta&amp;author=SR+Shiou&amp;author=PK+Datta&amp;author=P+Dhawan&amp;author=BK+Law&amp;author=JM+Yingling&amp;volume=281&amp;publication_year=2006&amp;pages=33971-33981&amp;pmid=16959768&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Madhunapantula1">50. <span class="mixed-citation">
Madhunapantula SV, Robertson GP (2009) <span class="ref-title">The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma</span>. <span class="ref-journal">Pigment Cell Melanoma Res</span>
<span class="ref-vol">22</span>: 400&#x02013;419. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3610526/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19493313" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pigment+Cell+Melanoma+Res&amp;title=The+PTEN-AKT3+signaling+cascade+as+a+therapeutic+target+in+melanoma&amp;author=SV+Madhunapantula&amp;author=GP+Robertson&amp;volume=22&amp;publication_year=2009&amp;pages=400-419&amp;pmid=19493313&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Biechele1">51. <span class="mixed-citation">
Biechele TL, Camp ND, Fass DM, Kulikauskas RM, Robin NC, et al. (2010) <span class="ref-title">Chemical-genetic screen identifies riluzole as an enhancer of Wnt/beta-catenin signaling in melanoma</span>. <span class="ref-journal">Chemistry &#x00026; Biology</span>
<span class="ref-vol">17</span>: 1177&#x02013;1182. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3044442/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21095567" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chemistry+&#x00026;+Biology&amp;title=Chemical-genetic+screen+identifies+riluzole+as+an+enhancer+of+Wnt/beta-catenin+signaling+in+melanoma&amp;author=TL+Biechele&amp;author=ND+Camp&amp;author=DM+Fass&amp;author=RM+Kulikauskas&amp;author=NC+Robin&amp;volume=17&amp;publication_year=2010&amp;pages=1177-1182&amp;pmid=21095567&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Matsuzaki1">52. <span class="mixed-citation">
Matsuzaki K, Kitano C, Murata M, Sekimoto G, Yoshida K, et al. (2009) <span class="ref-title">Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">69</span>: 5321&#x02013;5330. [<a href="https://pubmed.ncbi.nlm.nih.gov/19531654" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Smad2+and+Smad3+phosphorylated+at+both+linker+and+COOH-terminal+regions+transmit+malignant+TGF-beta+signal+in+later+stages+of+human+colorectal+cancer&amp;author=K+Matsuzaki&amp;author=C+Kitano&amp;author=M+Murata&amp;author=G+Sekimoto&amp;author=K+Yoshida&amp;volume=69&amp;publication_year=2009&amp;pages=5321-5330&amp;pmid=19531654&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Wildi1">53. <span class="mixed-citation">
Wildi S, Kleeff J, Maruyama H, Maurer CA, Buchler MW, et al. (2001) <span class="ref-title">Overexpression of activin A in stage IV colorectal cancer</span>. <span class="ref-journal">Gut</span>
<span class="ref-vol">49</span>: 409&#x02013;417. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1728425/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11511564" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Overexpression+of+activin+A+in+stage+IV+colorectal+cancer&amp;author=S+Wildi&amp;author=J+Kleeff&amp;author=H+Maruyama&amp;author=CA+Maurer&amp;author=MW+Buchler&amp;volume=49&amp;publication_year=2001&amp;pages=409-417&amp;pmid=11511564&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Yoshinaga1">54. <span class="mixed-citation">
Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, et al. (2004) <span class="ref-title">N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma</span>. <span class="ref-journal">Clin Cancer Res</span>
<span class="ref-vol">10</span>: 5702&#x02013;5707. [<a href="https://pubmed.ncbi.nlm.nih.gov/15355896" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=N-cadherin+is+regulated+by+activin+A+and+associated+with+tumor+aggressiveness+in+esophageal+carcinoma&amp;author=K+Yoshinaga&amp;author=H+Inoue&amp;author=T+Utsunomiya&amp;author=H+Sonoda&amp;author=T+Masuda&amp;volume=10&amp;publication_year=2004&amp;pages=5702-5707&amp;pmid=15355896&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Yoshinaga2">55. <span class="mixed-citation">
Yoshinaga K, Mimori K, Yamashita K, Utsunomiya T, Inoue H, et al. (2003) <span class="ref-title">Clinical significance of the expression of activin A in esophageal carcinoma</span>. <span class="ref-journal">Int J Oncol</span>
<span class="ref-vol">22</span>: 75&#x02013;80. [<a href="https://pubmed.ncbi.nlm.nih.gov/12469187" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Oncol&amp;title=Clinical+significance+of+the+expression+of+activin+A+in+esophageal+carcinoma&amp;author=K+Yoshinaga&amp;author=K+Mimori&amp;author=K+Yamashita&amp;author=T+Utsunomiya&amp;author=H+Inoue&amp;volume=22&amp;publication_year=2003&amp;pages=75-80&amp;pmid=12469187&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Yoshinaga3">56. <span class="mixed-citation">
Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, et al. (2008) <span class="ref-title">Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells</span>. <span class="ref-journal">Ann Surg Oncol</span>
<span class="ref-vol">15</span>: 96&#x02013;103. [<a href="https://pubmed.ncbi.nlm.nih.gov/17909904" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=Activin+a+causes+cancer+cell+aggressiveness+in+esophageal+squamous+cell+carcinoma+cells&amp;author=K+Yoshinaga&amp;author=K+Yamashita&amp;author=K+Mimori&amp;author=F+Tanaka&amp;author=H+Inoue&amp;volume=15&amp;publication_year=2008&amp;pages=96-103&amp;pmid=17909904&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Zhang1">57. <span class="mixed-citation">
Zhang DF, Li XG, Su LJ, Meng QL (2010) <span class="ref-title">Expression of activin A and follistatin in glioblastoma and their effects on U87 in vitro</span>. <span class="ref-journal">J Int Med Res</span>
<span class="ref-vol">38</span>: 1343&#x02013;1353. [<a href="https://pubmed.ncbi.nlm.nih.gov/20926007" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Int+Med+Res&amp;title=Expression+of+activin+A+and+follistatin+in+glioblastoma+and+their+effects+on+U87+in+vitro&amp;author=DF+Zhang&amp;author=XG+Li&amp;author=LJ+Su&amp;author=QL+Meng&amp;volume=38&amp;publication_year=2010&amp;pages=1343-1353&amp;pmid=20926007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Stove1">58. <span class="mixed-citation">
Stove C, Vanrobaeys F, Devreese B, Van Beeumen J, Mareel M, et al. (2004) <span class="ref-title">Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition</span>. <span class="ref-journal">Oncogene</span>
<span class="ref-vol">23</span>: 5330&#x02013;5339. [<a href="https://pubmed.ncbi.nlm.nih.gov/15064726" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Melanoma+cells+secrete+follistatin,+an+antagonist+of+activin-mediated+growth+inhibition&amp;author=C+Stove&amp;author=F+Vanrobaeys&amp;author=B+Devreese&amp;author=J+Van+Beeumen&amp;author=M+Mareel&amp;volume=23&amp;publication_year=2004&amp;pages=5330-5339&amp;pmid=15064726&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Shapiro1">59. <span class="mixed-citation">
Shapiro RL, Duquette JG, Roses DF, Nunes I, Harris MN, et al. (1996) <span class="ref-title">Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">56</span>: 3597&#x02013;3604. [<a href="https://pubmed.ncbi.nlm.nih.gov/8758932" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Induction+of+primary+cutaneous+melanocytic+neoplasms+in+urokinase-type+plasminogen+activator+(uPA)-deficient+and+wild-type+mice:+cellular+blue+nevi+invade+but+do+not+progress+to+malignant+melanoma+in+uPA-deficient+animals&amp;author=RL+Shapiro&amp;author=JG+Duquette&amp;author=DF+Roses&amp;author=I+Nunes&amp;author=MN+Harris&amp;volume=56&amp;publication_year=1996&amp;pages=3597-3604&amp;pmid=8758932&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Gutierrez1">60. <span class="mixed-citation">
Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, et al. (2000) <span class="ref-title">Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">60</span>: 5839&#x02013;5847. [<a href="https://pubmed.ncbi.nlm.nih.gov/11059781" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Tumor+development+is+retarded+in+mice+lacking+the+gene+for+urokinase-type+plasminogen+activator+or+its+inhibitor,+plasminogen+activator+inhibitor-1&amp;author=LS+Gutierrez&amp;author=A+Schulman&amp;author=T+Brito-Robinson&amp;author=F+Noria&amp;author=VA+Ploplis&amp;volume=60&amp;publication_year=2000&amp;pages=5839-5847&amp;pmid=11059781&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0047312-Ulisse1">61. <span class="mixed-citation">
Ulisse S, Baldini E, Sorrenti S, D&#x02019;Armiento M (2009) <span class="ref-title">The urokinase plasminogen activator system: a target for anti-cancer therapy</span>. <span class="ref-journal">Curr Cancer Drug Targets</span>
<span class="ref-vol">9</span>: 32&#x02013;71. [<a href="https://pubmed.ncbi.nlm.nih.gov/19200050" ref="reftype=pubmed&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Cancer+Drug+Targets&amp;title=The+urokinase+plasminogen+activator+system:+a+target+for+anti-cancer+therapy&amp;author=S+Ulisse&amp;author=E+Baldini&amp;author=S+Sorrenti&amp;author=M+D&#x02019;Armiento&amp;volume=9&amp;publication_year=2009&amp;pages=32-71&amp;pmid=19200050&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3470581&amp;issue-id=214865&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">PLOS ONE</span> are provided here courtesy of <strong>PLOS</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3470581/pdf/pone.0047312.pdf" class="int-view">PDF (1.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3470581/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3470581/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3470581" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3470581%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="n7moo1biUrfeJsudBUcBG00N7CHY93n4QlFxpxeRtkbzKBV55mTY4PJISjBghNL8">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3470581%2F&amp;text=Non-Canonical%20Smads%20Phosphorylation%20Induced%20by%20the%20Glutamate%20Release%20Inhibitor%2C%20Riluzole%2C%20through%20GSK3%20Activation%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3470581%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470581/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3470581/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/23077590/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3470581/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/23077590/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3470581/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3470581/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3470581/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
